data_1xc0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xc0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 120.458 0.108 . . . . 0.31 112.361 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 1.11 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.87 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.834 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.33 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.834 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.41 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.46 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 1.13 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.32 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.75 109.048 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.5 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.29 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.34 109.126 178.202 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.486 0.119 . . . . 0.27 112.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 1.09 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 1.07 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.82 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.29 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.82 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.35 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.89 106.388 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 1.03 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.28 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.51 109.177 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.42 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.23 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.25 109.55 178.474 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 120.548 0.145 . . . . 0.38 112.274 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 1.12 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 1.06 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.843 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.4 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.843 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.48 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.99 106.547 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 1.15 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.33 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.74 109.093 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 1.08 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.405 ' N ' HG11 ' A' ' 22' ' ' VAL . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.32 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.93 109.614 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.607 0.17 . . . . 0.35 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 1.07 111.21 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.7 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.37 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.738 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.41 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' A' ' 17' ' ' THR . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 1.28 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 1.11 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.42 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 1.1 109.306 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.96 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.21 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.33 109.528 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.49 1.31 0 N-CA-C 112.433 0.128 . . . . 0.35 112.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 1.12 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 1.24 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.842 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.44 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.842 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.47 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 1.6 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 1.17 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.47 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.99 109.356 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 1.15 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.23 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.35 109.234 178.375 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.533 0.139 . . . . 0.32 112.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.66 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.93 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.36 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.828 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.47 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 1.26 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 1.45 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.95 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 1.03 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 22' ' ' VAL . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.31 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.41 109.797 178.349 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.539 0.169 . . . . 0.4 112.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.94 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 1.02 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.841 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.42 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.841 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.5 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 1.0 106.423 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 1.13 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.44 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.72 109.013 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.82 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.36 107.654 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.59 109.736 178.377 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.6 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 112.925 0.317 . . . . 0.36 112.925 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 1.04 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.66 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.3 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.827 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.29 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 1.3 106.065 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.96 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.32 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.91 108.854 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.51 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.24 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.33 109.264 178.198 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.562 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo . . . . . 0 N--CA 1.493 1.492 0 N-CA-C 113.021 0.354 . . . . 0.29 113.021 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.69 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.7 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.826 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.25 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.826 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.4 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.45 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.72 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.42 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 1.06 109.253 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.74 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.21 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.39 109.926 178.438 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-O 120.58 0.158 . . . . 0.22 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.57 111.256 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 1.19 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.747 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.26 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.747 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.3 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 17' ' ' THR . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.47 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 1.14 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.99 109.361 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.48 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' N ' HG11 ' A' ' 22' ' ' VAL . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.25 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.46 109.547 178.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.9 Cg_endo . . . . . 0 N--CA 1.493 1.483 0 N-CA-C 112.623 0.201 . . . . 0.38 112.623 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 1.03 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 1.21 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.834 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.41 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.834 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.53 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.62 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 1.02 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.47 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 1.17 109.457 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.89 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.25 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.32 109.641 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.491 1.329 0 CA-C-O 120.791 0.246 . . . . 0.36 112.03 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 1.05 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.81 111.43 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.46 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.784 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.48 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' N ' HG23 ' A' ' 17' ' ' THR . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.63 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 1.06 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.43 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 1.07 109.076 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 1.16 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.31 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.38 109.23 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.8 Cg_endo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 120.567 0.153 . . . . 0.24 112.314 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.96 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.87 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.3 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.48 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.43 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.91 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.37 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.98 109.436 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 1.05 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.18 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.21 109.926 178.626 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.593 0.164 . . . . 0.34 112.071 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 1.13 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.9 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.4 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.788 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.41 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 1.13 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 1.14 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.32 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 1.11 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 1.19 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' N ' HG11 ' A' ' 22' ' ' VAL . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.31 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.64 109.308 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.485 0.119 . . . . 0.26 112.39 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.56 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.86 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.84 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.26 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.84 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.35 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.41 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.73 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.49 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.26 109.23 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 1.05 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.16 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.61 109.712 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 N-CA-C 112.423 0.124 . . . . 0.31 112.423 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 1.08 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 1.02 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.34 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.835 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 1.13 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 1.17 106.045 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 1.02 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.36 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 1.15 108.77 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.91 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.28 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.32 109.419 178.24 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.608 0.17 . . . . 0.33 112.205 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.98 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 1.38 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.831 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.35 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.831 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.43 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.52 106.035 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 1.14 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.72 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 1.08 109.406 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.49 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.3 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.69 109.888 178.326 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.1 Cg_endo . . . . . 0 N--CA 1.493 1.477 0 N-CA-C 113.025 0.356 . . . . 0.37 113.025 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.565 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.84 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.7 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.39 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.827 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.44 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.48 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 1.15 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.46 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.8 109.389 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.49 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.21 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.26 109.556 178.291 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.488 0.12 . . . . 0.3 112.313 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.69 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 1.03 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.822 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.43 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.822 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.54 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 1.25 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 1.12 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.43 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 1.17 108.951 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 1.12 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' N ' HG11 ' A' ' 22' ' ' VAL . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.38 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.51 109.565 178.277 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.45 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.6 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.54 0.142 . . . . 0.33 112.373 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 1.2 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.59 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.36 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.837 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.37 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 1.21 106.22 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.7 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.31 107.088 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 1.07 109.124 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.84 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' A' ' 22' ' ' VAL . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.25 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.31 109.48 178.461 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.828 0 N-CA-C 109.688 -1.365 . . . . 1.1 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.638 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.31 -59.48 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.402 -1.057 . . . . 0.65 108.271 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.602 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.23 -38.58 0.2 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 118.574 -1.251 . . . . 0.45 113.17 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.251 . . -173.13 -48.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.82 112.139 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.602 ' HG ' ' CZ ' ' A' ' 3' ' ' PHE . 1.4 pp -116.26 -3.9 11.94 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.207 -0.933 . . . . 1.03 110.874 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.715 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.9 -41.68 2.25 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 118.969 -1.092 . . . . 0.4 111.576 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.715 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 47.8 Cg_endo -69.99 -15.07 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 122.468 0.72 . . . . 0.31 111.254 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.602 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.51 -30.55 11.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.744 -1.222 . . . . 0.52 109.326 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.62 -30.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.295 -1.002 . . . . 0.39 108.295 178.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.615 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.4 pt -83.88 17.39 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.21 0 C-N-CA 118.597 -1.241 . . . . 0.76 109.194 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.3 t -50.27 -41.54 50.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.639 -1.288 . . . . 0.68 108.874 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -67.75 -58.51 8.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.388 -0.82 . . . . 0.48 109.871 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.23 26.81 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.97 1.113 . . . . 0.31 112.361 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 1.11 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.623 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.87 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.834 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.33 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.834 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.41 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.46 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 1.13 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.32 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.75 109.048 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.5 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.29 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.9 m -99.68 -27.53 13.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.34 109.126 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -84.66 -20.47 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.355 -0.84 . . . . 0.93 110.323 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.03 -40.64 4.43 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.735 -0.603 . . . . 1.48 109.751 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -82.09 -35.75 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.63 109.51 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -94.3 -59.72 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.692 -1.225 . . . . 0.48 107.692 178.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -80.24 170.9 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.676 -1.231 . . . . 0.31 107.676 176.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.64 -61.54 2.42 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 108.753 -1.739 . . . . 0.43 108.753 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -75.51 -44.71 20.53 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.893 -1.683 . . . . 0.55 108.893 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 19.2 mt-30 60.06 54.35 4.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.804 -0.821 . . . . 0.83 110.858 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.87 -1.062 . . . . 0.87 110.359 179.692 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.809 0 N-CA-C 109.642 -1.383 . . . . 1.21 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.685 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -150.92 -61.18 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 107.975 -1.12 . . . . 0.61 107.975 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.7 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 40.4 p90 -145.71 -38.19 0.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 118.547 -1.261 . . . . 0.35 113.045 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.73 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.013 -1.054 . . . . 0.4 112.399 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.7 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -124.22 -0.17 8.33 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.45 110.625 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.772 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -42.67 -33.49 0.69 Allowed Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.155 -1.018 . . . . 0.59 112.093 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.772 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.9 Cg_endo -92.4 -0.14 4.01 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 O-C-N 122.469 0.72 . . . . 0.35 111.667 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 7.0 mppt? -107.23 -32.28 7.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.618 -1.301 . . . . 0.44 110.197 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.645 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.33 -30.22 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.44 108.429 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.622 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 pt -83.28 16.9 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 C-N-CA 118.809 -1.156 . . . . 0.75 109.095 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.645 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.1 t -50.18 -40.74 47.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.74 -1.225 . . . . 0.48 108.982 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -69.27 -58.76 5.71 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.34 109.698 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.2 Cg_endo -82.71 29.49 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.258 1.136 . . . . 0.27 112.371 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 1.09 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 1.07 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.82 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.29 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.82 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.35 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.89 106.388 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 1.03 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.28 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.51 109.177 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.42 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.23 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 39.0 m -98.36 -23.37 15.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.25 109.55 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.29 -23.37 21.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.134 -0.979 . . . . 0.76 109.469 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.35 -45.25 5.65 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.757 0.789 . . . . 1.38 109.105 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -86.57 -36.21 19.03 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.759 -0.588 . . . . 0.27 111.123 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -90.87 -25.19 19.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.346 -1.472 . . . . 0.34 111.563 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 t -117.0 21.95 12.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.51 111.056 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.45 -57.2 0.01 OUTLIER Glycine 0 N--CA 1.5 2.941 0 C-N-CA 119.678 -1.249 . . . . 0.51 110.407 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -162.76 97.96 0.16 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 108.755 -1.738 . . . . 0.42 108.755 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 124.54 20.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.659 -0.906 . . . . 0.61 111.524 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.339 -0.838 . . . . 0.67 110.402 179.243 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.589 -1.404 . . . . 1.36 109.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.47 -60.65 0.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.336 -1.097 . . . . 1.17 108.106 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.0 p90 -146.65 -39.05 0.21 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.914 -1.114 . . . . 0.81 112.687 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.56 -55.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.999 -1.063 . . . . 1.26 112.26 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.682 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.18 -1.28 23.81 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.537 -0.727 . . . . 0.96 110.035 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -36.43 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.502 2.175 0 O-C-N 121.346 -0.846 . . . . 0.63 112.229 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.654 ' HD2' ' C ' ' A' ' 5' ' ' LEU . 43.5 Cg_endo -67.1 -16.87 50.2 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 122.31 0.637 . . . . 0.66 111.021 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -97.9 -24.49 15.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.872 -1.143 . . . . 0.94 109.569 178.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -63.68 -29.63 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.368 -0.975 . . . . 0.46 108.368 178.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.623 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 12.6 pt -85.37 18.37 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 C-N-CA 118.49 -1.284 . . . . 1.2 108.73 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 8.5 t -50.61 -41.9 55.41 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.801 -1.187 . . . . 0.63 108.968 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.616 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.56 -58.06 7.56 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.42 109.828 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.2 Cg_endo -82.81 30.38 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.986 1.124 . . . . 0.38 112.274 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 1.12 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.653 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 1.06 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.843 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.4 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.843 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.48 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.99 106.547 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 1.15 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.33 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.74 109.093 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 1.08 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.32 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' SER . 11.2 t -97.47 -23.79 15.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.93 109.614 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -91.4 -21.32 21.04 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.168 -0.958 . . . . 0.72 109.675 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.22 -37.33 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.738 -0.601 . . . . 1.4 109.557 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -96.1 -23.84 16.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.686 -0.634 . . . . 0.52 111.454 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -109.17 -66.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.077 -1.014 . . . . 0.74 110.592 -179.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 28.0 t -87.5 51.39 2.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.951 -1.093 . . . . 0.55 109.818 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.7 -73.31 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.279 -1.129 . . . . 0.46 110.279 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.98 77.16 0.25 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.229 -1.148 . . . . 0.58 110.229 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -35.05 28.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.418 -1.048 . . . . 1.36 110.778 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 118.428 -0.796 . . . . 0.96 110.937 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.814 0 N-CA-C 109.819 -1.312 . . . . 1.46 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.609 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.55 -59.95 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.364 -1.08 . . . . 1.25 108.165 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.655 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.3 p90 -146.76 -38.92 0.21 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.066 -1.054 . . . . 0.98 112.684 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.26 -54.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 1.07 112.304 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.655 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -108.39 -1.88 19.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.454 -0.779 . . . . 1.02 110.406 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.653 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -37.69 -41.57 0.99 Allowed Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.339 -0.944 . . . . 0.78 111.915 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.653 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 44.6 Cg_endo -67.61 -15.01 43.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 122.392 0.68 . . . . 0.72 111.027 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -97.28 -29.29 13.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.865 -1.147 . . . . 0.77 109.733 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -68.02 -33.35 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.864 -1.162 . . . . 0.6 107.864 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.603 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.6 pt -87.48 19.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.719 -1.192 . . . . 0.61 108.268 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 26.6 t -51.37 -39.63 57.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.007 -1.058 . . . . 0.61 108.788 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.647 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.54 -59.53 5.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.906 . . . . 0.67 109.534 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.0 Cg_endo -84.31 37.36 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.058 1.172 . . . . 0.35 111.928 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 1.07 111.21 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.675 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.7 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.37 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.738 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.41 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' A' ' 17' ' ' THR . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 1.28 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 1.11 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.42 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 1.1 109.306 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.96 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.21 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' SER . 34.3 m -97.99 -23.15 15.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.33 109.528 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.44 -21.3 23.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.818 -1.176 . . . . 1.08 109.558 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.42 -44.87 5.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.852 -0.796 . . . . 1.58 108.852 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 t -82.98 -40.62 19.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.71 -0.619 . . . . 0.34 110.559 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -91.69 -62.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.44 111.037 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 t -71.97 -10.24 59.5 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.912 -1.117 . . . . 0.63 111.404 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.02 36.72 3.44 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.077 -1.209 . . . . 0.53 110.077 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 157.19 -47.21 0.47 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.104 -1.199 . . . . 0.58 110.104 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.9 OUTLIER 76.71 140.23 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.493 0.663 . . . . 0.69 110.789 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.95 -1.024 . . . . 0.63 110.687 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.913 0 N-CA-C 109.725 -1.35 . . . . 0.95 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.621 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.77 -60.12 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.359 -1.083 . . . . 1.06 108.198 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.28 -38.8 0.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 118.595 -1.242 . . . . 0.8 113.194 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.75 -48.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.979 -1.076 . . . . 0.84 112.039 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.661 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -116.56 -3.6 11.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.206 -0.934 . . . . 1.2 110.911 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.716 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.13 -41.75 2.49 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 118.929 -1.108 . . . . 0.99 111.592 179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.716 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 48.5 Cg_endo -70.23 -15.11 35.25 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.499 0.736 . . . . 0.52 111.323 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 3.0 mppt? -100.72 -30.76 11.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.669 -1.27 . . . . 0.63 109.228 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.639 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.57 -30.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.415 -0.957 . . . . 0.53 108.415 178.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.609 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.7 pt -83.87 18.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 C-N-CA 118.562 -1.255 . . . . 0.38 109.145 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 4.5 t -50.55 -41.14 53.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.702 -1.249 . . . . 0.74 108.831 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.588 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.69 -59.05 7.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.55 109.915 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.4 Cg_endo -82.87 27.18 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 O-C-N 123.283 1.149 . . . . 0.35 112.433 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 1.12 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 1.24 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.842 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.44 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.842 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.47 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 1.6 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 1.17 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.47 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.99 109.356 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 1.15 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.23 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 28' ' ' SER . 28.6 m -96.74 -27.43 14.75 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.35 109.234 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.49 -25.0 25.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.065 -1.022 . . . . 1.09 110.194 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -101.58 -47.66 4.57 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.386 -0.598 . . . . 1.56 109.386 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -78.44 -37.87 42.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.655 -0.653 . . . . 0.41 111.34 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -83.91 0.86 46.07 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.725 -1.235 . . . . 0.67 111.015 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -90.34 -42.47 10.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.081 -1.012 . . . . 0.57 110.364 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.28 54.77 0.75 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.275 -1.13 . . . . 0.71 110.275 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 -59.46 3.93 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.206 -1.173 . . . . 0.82 110.395 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' C ' ' HA ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -158.16 -169.55 2.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.574 -0.957 . . . . 0.69 110.561 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HG3' HD23 ' A' ' 26' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.87 -1.062 . . . . 0.68 110.555 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 109.595 -1.402 . . . . 1.11 109.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.64 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.05 -59.49 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.352 -1.087 . . . . 0.69 108.277 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.619 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -147.02 -38.81 0.2 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.548 -1.261 . . . . 0.53 113.153 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.253 . . -172.99 -47.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.071 . . . . 0.5 112.096 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.67 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.5 pp -116.7 -4.27 11.67 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.12 -0.988 . . . . 1.14 110.856 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.715 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.8 -41.81 2.24 Favored Pre-proline 0 N--CA 1.501 2.093 0 C-N-CA 119.06 -1.056 . . . . 0.48 111.674 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.715 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 45.3 Cg_endo -69.28 -14.26 37.29 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 122.405 0.687 . . . . 0.33 111.256 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.605 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.64 -31.59 10.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.853 -1.154 . . . . 0.46 109.446 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.67 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.63 -30.55 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.329 -0.989 . . . . 0.44 108.329 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.617 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.7 pt -84.19 17.56 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 118.596 -1.242 . . . . 0.84 109.248 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 7.0 t -50.19 -40.67 47.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.731 -1.23 . . . . 0.72 108.964 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.579 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.81 -58.94 7.32 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.401 -0.812 . . . . 0.62 109.795 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.617 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.08 27.2 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.286 1.151 . . . . 0.32 112.341 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.66 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.579 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.93 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.36 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.828 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.47 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 1.26 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 1.45 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.95 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 1.03 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.31 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' SER . 9.1 p -97.63 -23.64 15.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.41 109.797 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -91.74 -17.3 25.61 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.23 -0.919 . . . . 1.09 110.159 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -107.4 -48.17 3.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.021 -1.104 . . . . 1.22 108.021 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.582 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -76.89 -42.14 40.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.745 -0.597 . . . . 0.47 109.434 178.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -93.54 40.57 1.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.945 -1.097 . . . . 0.42 108.972 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.57 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 88.4 p -102.22 -70.81 0.74 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.581 -0.7 . . . . 0.43 110.981 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -122.62 51.64 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.523 -1.431 . . . . 0.66 109.523 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.84 47.82 30.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 108.778 -1.729 . . . . 0.72 108.778 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -113.98 36.37 3.72 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.642 -0.916 . . . . 1.46 110.517 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.174 -0.954 . . . . 0.84 110.419 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.909 0 N-CA-C 109.602 -1.399 . . . . 1.11 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.633 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.21 -59.93 0.08 Allowed 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.285 -1.127 . . . . 0.9 108.183 179.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.8 p90 -147.41 -39.16 0.19 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 118.54 -1.264 . . . . 0.64 113.259 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.47 -47.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.69 112.104 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.645 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -116.79 -3.51 11.69 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.194 -0.942 . . . . 0.82 110.816 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.71 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.41 -41.63 2.66 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 118.903 -1.119 . . . . 0.48 111.553 179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.71 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 47.2 Cg_endo -70.1 -14.92 35.59 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 122.456 0.714 . . . . 0.4 111.198 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 2.9 mppt? -101.75 -30.02 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.77 -1.206 . . . . 0.64 109.293 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.613 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.74 -30.41 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.405 -0.961 . . . . 0.5 108.405 178.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.8 pt -84.05 18.82 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 C-N-CA 118.553 -1.259 . . . . 0.43 108.964 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.677 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 10.1 t -50.96 -41.15 58.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.685 -1.259 . . . . 0.74 108.889 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.79 -58.46 6.68 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.803 . . . . 0.57 110.026 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.616 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.4 Cg_endo -82.83 25.92 0.66 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.01 1.14 . . . . 0.4 112.539 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.94 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.677 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 1.02 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.841 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.42 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.841 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.5 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 1.0 106.423 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 1.13 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.44 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.72 109.013 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.82 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.36 107.654 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 6.2 t -97.44 -20.32 17.85 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.59 109.736 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.74 -20.99 19.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.08 -1.012 . . . . 1.17 109.463 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -34.43 9.26 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.19 -0.67 . . . . 1.38 109.19 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.45 111.109 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.594 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -113.32 39.95 2.48 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.846 -1.159 . . . . 0.84 110.942 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -139.14 -48.39 0.49 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.193 -0.942 . . . . 0.62 110.606 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.4 54.93 0.62 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.839 -1.704 . . . . 0.89 108.839 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.78 59.88 0.34 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.423 -1.871 . . . . 0.89 108.423 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.5 tt0 -51.49 137.46 24.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.881 -0.776 . . . . 0.86 111.247 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.316 -0.85 . . . . 1.03 110.482 179.619 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.785 0 N-CA-C 109.748 -1.341 . . . . 1.21 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.604 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.0 -59.82 0.08 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.333 -1.098 . . . . 0.64 108.177 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.708 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -145.98 -39.52 0.23 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.09 -1.044 . . . . 0.43 112.446 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.41 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.6 112.349 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.89 -1.05 16.63 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.457 -0.777 . . . . 1.0 110.445 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.663 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.66 -40.7 1.07 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 119.414 -0.914 . . . . 0.38 112.181 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.663 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 43.7 Cg_endo -68.26 -14.38 40.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.326 0.645 . . . . 0.33 110.774 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.596 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.15 -27.05 13.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.869 -1.144 . . . . 0.77 109.896 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -67.19 -31.09 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.964 -1.124 . . . . 0.39 107.964 178.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.724 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 2.9 pt -88.97 20.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.716 -1.194 . . . . 0.31 108.626 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 6.0 p -54.32 -32.45 56.65 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.852 -1.155 . . . . 0.31 108.721 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.56 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -85.5 -55.56 0.4 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.356 -0.84 . . . . 0.47 110.363 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 54.6 Cg_endo -81.3 20.88 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.952 1.101 . . . . 0.36 112.925 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 1.04 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 11' ' ' SER . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.66 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.3 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.827 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.29 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 1.3 106.065 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.96 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.32 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.91 108.854 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.51 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.24 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 p -97.55 -22.01 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.33 109.264 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.22 -23.88 19.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.92 -1.113 . . . . 1.15 109.347 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -35.58 9.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.369 0.604 . . . . 1.26 109.651 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.735 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -98.7 -31.43 11.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.679 -0.638 . . . . 0.29 111.712 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.581 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -86.53 3.72 43.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.919 -1.113 . . . . 0.37 110.835 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -96.25 -46.29 6.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.904 . . . . 0.45 109.911 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.33 28.1 4.11 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.512 -1.435 . . . . 0.52 109.512 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 55.83 26.49 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.625 -1.39 . . . . 0.48 109.625 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.735 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 52.0 tp60 -63.84 -64.59 0.85 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -1.053 . . . . 0.66 110.431 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.918 -1.039 . . . . 0.63 110.613 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 109.692 -1.363 . . . . 1.06 109.692 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.609 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.74 -59.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.086 -1.079 . . . . 0.51 108.086 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.9 p90 -146.45 -39.04 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.143 -1.023 . . . . 0.39 112.362 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 -54.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.341 -0.944 . . . . 1.0 112.397 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.689 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.3 pp -110.51 -0.96 17.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.418 -0.802 . . . . 1.06 110.375 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.669 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.42 -40.81 1.03 Allowed Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.245 -0.909 . . . . 0.39 112.126 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.669 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 44.4 Cg_endo -68.53 -15.03 41.07 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 122.309 0.636 . . . . 0.31 110.731 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.6 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -99.92 -26.22 14.07 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.48 109.645 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HB ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -66.84 -30.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.93 -1.137 . . . . 0.4 107.93 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 pt -88.37 19.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 118.738 -1.185 . . . . 0.39 108.754 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 6.4 p -54.4 -32.12 56.54 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.808 -1.183 . . . . 0.25 108.827 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.512 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -85.43 -55.66 0.4 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.45 110.278 178.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.562 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo -81.6 19.55 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.08 1.187 . . . . 0.29 113.021 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.69 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.7 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.826 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.25 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.826 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.4 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.45 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.72 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.42 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 1.06 109.253 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.74 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.21 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.612 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.3 t -97.94 -25.63 14.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.39 109.926 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.76 21.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.799 -1.188 . . . . 0.39 109.841 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.16 -45.2 5.45 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.269 -0.641 . . . . 1.16 109.269 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -82.4 -33.65 28.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.26 111.304 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.612 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -86.25 15.12 5.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.28 110.567 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -105.88 -57.64 2.02 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.351 -0.843 . . . . 0.33 109.329 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.59 15.08 3.88 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.384 -1.086 . . . . 0.4 110.384 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.15 -53.62 0.77 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.86 -1.296 . . . . 0.33 109.86 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 1.4 tt0 -166.96 -51.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.343 -1.092 . . . . 0.53 111.06 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.119 -0.944 . . . . 0.4 111.036 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.932 0 N-CA-C 109.708 -1.357 . . . . 1.19 109.708 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.63 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.63 -59.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.304 -1.115 . . . . 0.71 108.296 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.671 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -146.89 -39.14 0.21 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 118.61 -1.236 . . . . 0.37 113.364 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.5 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.979 -1.075 . . . . 0.48 112.306 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.671 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -116.54 -4.43 11.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.257 -0.902 . . . . 0.45 110.845 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.775 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.97 -40.83 1.86 Allowed Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 118.994 -1.083 . . . . 0.43 111.963 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.775 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 55.1 Cg_endo -75.18 -11.45 21.16 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 122.335 0.65 . . . . 0.33 111.634 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 3.5 mppt? -99.98 -36.66 9.3 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.684 -1.26 . . . . 0.46 110.536 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.666 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -63.4 -33.12 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.143 -0.973 . . . . 0.4 108.502 178.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.6 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 8.5 pt -84.36 19.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.5 -1.28 . . . . 0.35 108.527 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.8 t -51.02 -41.25 59.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.938 -1.101 . . . . 0.42 108.959 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.659 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -66.86 -59.41 7.83 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.61 109.629 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.6 Cg_endo -83.64 35.85 0.58 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.022 1.148 . . . . 0.22 112.047 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.57 111.256 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 1.19 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.747 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.26 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.747 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.3 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 17' ' ' THR . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.47 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 1.14 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.99 109.361 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.48 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.25 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 44.3 t -97.46 -23.57 16.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.46 109.547 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -88.23 -22.6 23.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.92 109.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -101.03 -46.22 5.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.849 -0.797 . . . . 1.18 108.849 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 2.3 t -81.62 -39.23 24.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.29 110.719 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -94.27 -61.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 0.27 110.974 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 8.2 t -73.9 -6.31 46.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.984 -1.072 . . . . 0.46 111.767 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.9 -71.52 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.658 -1.377 . . . . 0.44 109.658 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -77.96 -14.19 82.58 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.435 -1.038 . . . . 0.38 111.178 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 18.3 mm-40 59.77 38.14 21.71 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.408 -1.054 . . . . 0.63 111.085 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 118.89 -0.576 . . . . 0.57 111.308 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 109.656 -1.378 . . . . 1.24 109.656 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.636 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.89 -59.66 0.06 Allowed 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.277 -1.131 . . . . 0.93 108.217 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.5 p90 -147.09 -38.96 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.632 -1.227 . . . . 0.69 113.096 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.52 -48.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 1.04 112.129 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -116.6 -3.4 11.8 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.167 -0.958 . . . . 0.67 110.848 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.722 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.16 -41.7 2.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 C-N-CA 118.916 -1.114 . . . . 0.43 111.56 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.722 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 48.4 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.444 0.707 . . . . 0.38 111.305 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -101.21 -30.46 11.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.82 -1.175 . . . . 0.64 109.343 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.98 -30.22 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.406 -0.961 . . . . 0.39 108.406 178.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.604 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.3 pt -84.33 18.4 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.297 0 C-N-CA 118.536 -1.265 . . . . 0.91 108.931 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.1 t -50.6 -42.89 56.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.709 -1.244 . . . . 0.64 109.012 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.579 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -66.94 -58.37 9.57 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.842 . . . . 0.89 109.992 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.9 Cg_endo -81.99 24.54 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.091 1.194 . . . . 0.38 112.623 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 1.03 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 1.21 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.834 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.41 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.834 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.53 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.62 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 1.02 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.47 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 1.17 109.457 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.89 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.25 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.4 m -96.9 -24.85 15.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.32 109.641 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.54 -22.05 21.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.47 110.305 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' VAL . 2.1 tt -104.87 -42.04 5.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.327 -0.62 . . . . 1.41 109.327 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -87.05 -27.27 23.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.762 -0.586 . . . . 0.47 111.061 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -107.36 -56.46 2.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.923 -1.11 . . . . 0.36 110.208 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 11.0 m -86.55 41.31 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.48 110.428 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.59 -75.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.818 -1.313 . . . . 0.58 109.818 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.94 72.96 0.22 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.656 -1.377 . . . . 0.6 109.656 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -98.87 -57.85 2.08 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.985 . . . . 0.68 111.057 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.865 -1.064 . . . . 0.92 110.514 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.83 0 N-CA-C 109.734 -1.346 . . . . 1.47 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.64 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.49 -60.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.394 -1.063 . . . . 1.08 108.151 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.4 p90 -146.54 -39.19 0.21 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.929 -1.108 . . . . 0.89 112.665 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.61 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.096 -1.002 . . . . 1.16 112.272 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -107.29 -1.42 21.72 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.409 -0.807 . . . . 1.1 110.205 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -36.85 -41.86 0.77 Allowed Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 121.316 -0.865 . . . . 0.94 112.09 179.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' HD2' ' C ' ' A' ' 5' ' ' LEU . 43.9 Cg_endo -67.34 -16.8 48.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 122.307 0.635 . . . . 0.64 110.907 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -95.3 -25.99 16.1 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.935 -1.103 . . . . 0.84 109.669 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 ' HB ' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -70.19 -33.99 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.775 -1.194 . . . . 0.52 107.775 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 3.3 pt -90.7 18.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 118.978 -1.089 . . . . 0.45 108.385 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 27.4 p -55.23 -32.89 62.64 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.017 -1.052 . . . . 0.37 108.765 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.66 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -86.89 -55.05 0.37 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.75 109.567 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -84.49 44.22 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.159 1.24 . . . . 0.36 112.03 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 1.05 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.575 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.81 111.43 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.46 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.784 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.48 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' N ' HG23 ' A' ' 17' ' ' THR . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.63 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 1.06 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.43 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 1.07 109.076 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 1.16 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.31 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 50.4 m -95.34 -24.67 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.38 109.23 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.24 -23.43 20.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 1.23 110.084 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 -42.28 6.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.702 0.763 . . . . 1.39 109.278 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -89.57 -34.01 16.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.715 -0.616 . . . . 0.4 111.331 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.628 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -90.75 -41.21 11.39 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.681 -1.262 . . . . 0.44 110.843 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -36.86 22.99 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.95 -1.094 . . . . 0.63 110.278 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -62.11 1.18 Allowed Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.589 -1.404 . . . . 0.69 109.589 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.61 -13.68 74.73 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.446 -1.032 . . . . 0.68 110.833 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 64.37 30.75 13.14 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.436 -1.038 . . . . 0.86 111.175 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.423 -0.798 . . . . 0.74 110.237 179.612 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.893 0 N-CA-C 109.689 -1.365 . . . . 1.02 109.689 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.673 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.12 -60.74 0.22 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.95 -1.13 . . . . 0.54 107.95 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.774 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 39.3 p90 -146.47 -38.21 0.23 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 118.405 -1.318 . . . . 0.35 113.237 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.54 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.953 -1.092 . . . . 0.43 112.509 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.774 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 3.7 pp -125.61 -1.42 7.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.35 -0.844 . . . . 0.38 110.699 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.779 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -42.5 -33.89 0.73 Allowed Pre-proline 0 N--CA 1.496 1.85 0 C-N-CA 119.213 -0.995 . . . . 1.05 111.969 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.0 Cg_endo -94.27 6.43 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 O-C-N 122.58 0.779 . . . . 0.28 111.403 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 8.9 mtpt -110.27 -39.63 4.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.667 -1.27 . . . . 0.4 110.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.537 HG22 HD11 ' A' ' 5' ' ' LEU . 2.2 pp -60.22 -28.96 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.015 -1.053 . . . . 0.46 109.385 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.644 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 1.1 pp -92.31 17.69 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 118.062 -1.455 . . . . 0.81 109.452 177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 12.0 t -50.63 -41.3 54.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.864 -1.148 . . . . 0.44 108.843 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.592 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -65.19 -59.99 8.76 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.452 -0.78 . . . . 0.69 109.559 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 54.8 Cg_endo -83.39 32.66 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.995 1.13 . . . . 0.24 112.314 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.605 ' CB ' HD13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.96 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.87 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.832 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.3 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.48 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.43 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.91 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.37 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.98 109.436 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 1.05 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.18 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 28' ' ' SER . 18.8 m -95.35 -24.46 16.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.21 109.926 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.66 -15.92 24.83 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 0.73 110.395 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -107.78 -36.24 6.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.459 -0.776 . . . . 1.2 108.932 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -97.19 -30.18 13.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.27 111.053 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -106.98 24.48 12.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.134 . . . . 0.28 112.333 -178.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.4 p -114.51 -47.98 2.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.038 -1.039 . . . . 0.32 110.205 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.35 55.26 4.22 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.62 -1.392 . . . . 0.39 109.62 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . 138.26 -27.8 2.73 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.41 109.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 75.6 138.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.653 0.739 . . . . 0.4 111.307 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.949 -1.024 . . . . 0.51 109.964 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.728 -1.349 . . . . 1.42 109.728 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.621 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.35 -60.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.33 -1.1 . . . . 1.03 108.249 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.0 p90 -146.81 -39.2 0.21 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.633 -1.227 . . . . 0.83 113.192 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.55 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.84 112.155 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.73 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.9 pp -117.31 -4.28 11.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.104 -0.998 . . . . 0.96 110.721 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.724 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.58 -41.87 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 118.992 -1.083 . . . . 0.51 111.74 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.724 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 46.1 Cg_endo -69.69 -15.22 37.24 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 122.481 0.727 . . . . 0.52 111.264 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.606 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -99.33 -32.0 11.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.76 -1.212 . . . . 0.5 109.623 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.73 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -61.84 -31.58 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.117 -1.068 . . . . 0.56 108.117 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.606 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.0 pt -84.21 18.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 118.666 -1.214 . . . . 1.13 109.143 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.619 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 28.7 t -51.54 -40.73 60.23 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.77 -1.206 . . . . 0.54 108.831 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -70.13 -57.96 5.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.47 109.507 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.7 Cg_endo -84.28 39.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.101 1.201 . . . . 0.34 112.071 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 1.13 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.619 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.9 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.4 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.788 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.41 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 1.13 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 1.14 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.32 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 1.11 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.458 ' HA ' ' HB1' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 1.19 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.31 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.4 OUTLIER -99.85 -23.81 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.64 109.308 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 22' ' ' VAL . . . -87.65 -21.8 25.08 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.985 -1.072 . . . . 1.1 109.282 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -101.61 -44.43 5.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.113 -0.699 . . . . 1.12 109.113 179.314 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.12 -43.24 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.73 -0.606 . . . . 0.35 111.146 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -75.46 -10.47 59.48 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.797 -1.189 . . . . 0.47 110.767 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 20.4 t -121.75 18.95 11.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.56 110.52 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.76 57.05 0.03 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.148 -1.181 . . . . 0.45 110.148 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.78 68.9 0.2 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.418 -1.473 . . . . 0.51 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -93.44 -21.54 19.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.564 -0.962 . . . . 0.63 110.728 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.502 -0.761 . . . . 0.98 110.852 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.789 0 N-CA-C 109.704 -1.359 . . . . 1.19 109.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.678 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.26 -60.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.155 -1.054 . . . . 0.72 108.155 179.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.659 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.4 p90 -146.95 -39.35 0.2 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.764 -1.175 . . . . 0.42 112.81 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.48 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.967 -1.083 . . . . 0.72 112.228 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.659 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -105.84 -1.34 24.37 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.491 -0.756 . . . . 1.08 109.988 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.678 ' HB ' ' HB3' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -36.45 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.503 2.179 0 C-N-CA 119.683 -0.807 . . . . 0.42 112.183 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HD2' ' C ' ' A' ' 5' ' ' LEU . 43.2 Cg_endo -66.89 -17.01 51.41 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 122.276 0.619 . . . . 0.38 110.837 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -99.06 -24.43 14.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.857 -1.152 . . . . 0.73 109.457 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -29.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.314 -0.995 . . . . 0.43 108.314 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.612 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -84.94 18.13 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.228 0 C-N-CA 118.659 -1.216 . . . . 0.64 108.685 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.6 t -50.57 -40.53 52.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.721 -1.237 . . . . 0.48 108.881 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.588 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -69.01 -58.44 6.38 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.44 109.883 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.612 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.09 26.4 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.086 1.191 . . . . 0.26 112.39 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.56 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.636 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.86 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.84 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.26 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.84 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.35 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.41 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.73 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.49 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.26 109.23 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 1.05 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.16 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 30.9 t -98.91 -25.71 14.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.61 109.712 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -86.65 -21.72 26.56 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.023 -1.048 . . . . 0.97 109.792 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.46 -42.51 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.209 -0.663 . . . . 1.09 109.209 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -88.62 -42.82 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.21 110.872 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -76.36 -13.8 60.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.719 -1.238 . . . . 0.29 110.819 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 22.3 t -117.98 19.78 13.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.092 -1.005 . . . . 0.33 110.489 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.42 53.53 0.02 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 110.487 -1.045 . . . . 0.3 110.487 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.96 63.73 0.05 OUTLIER Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.965 -1.254 . . . . 0.28 109.965 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 1.7 mm100 -76.06 -49.29 17.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.43 -1.041 . . . . 0.36 110.287 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.838 -1.077 . . . . 0.68 110.452 179.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.908 0 N-CA-C 109.636 -1.386 . . . . 1.19 109.636 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.626 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.94 -59.85 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.343 -1.092 . . . . 0.66 108.283 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.726 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.1 p90 -147.8 -38.96 0.19 Allowed 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 118.538 -1.265 . . . . 0.48 113.233 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.45 -48.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.872 -1.143 . . . . 0.99 112.187 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.726 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.7 pp -116.66 -3.37 11.77 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.127 -0.983 . . . . 1.0 110.762 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.72 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.32 -41.68 2.61 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 118.939 -1.105 . . . . 0.43 111.552 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.72 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 46.6 Cg_endo -69.56 -15.21 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 122.521 0.748 . . . . 0.38 111.308 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -100.96 -30.75 11.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.769 -1.207 . . . . 0.54 109.34 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.632 ' HB ' HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.78 -29.93 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.379 -0.971 . . . . 0.41 108.379 178.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.619 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -83.84 18.25 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.595 -1.242 . . . . 0.97 108.973 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.666 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 5.0 t -50.8 -41.77 57.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.637 -1.289 . . . . 0.71 108.94 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.26 -58.2 7.84 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.407 -0.808 . . . . 0.47 109.963 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.619 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.3 Cg_endo -82.69 26.16 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 O-C-N 123.264 1.139 . . . . 0.31 112.423 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 1.08 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 1.02 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.835 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.34 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.835 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 1.13 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 1.17 106.045 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 1.02 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.36 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 1.15 108.77 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.91 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.28 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 5.1 p -97.56 -23.14 16.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.32 109.419 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.37 -19.79 22.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.048 -1.032 . . . . 0.79 109.653 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.56 -33.15 8.19 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.487 0.66 . . . . 1.21 109.741 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -101.89 -29.07 12.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.48 111.728 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.556 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -92.54 -46.71 7.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 0.36 111.146 -179.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.6 p -50.01 -28.95 7.7 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.381 -0.825 . . . . 0.55 112.036 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.8 6.15 75.54 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.092 -1.005 . . . . 0.72 111.422 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 119.58 -16.99 10.37 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.913 -1.346 . . . . 0.71 110.46 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 63.2 tp60 67.16 -75.95 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.753 -0.851 . . . . 0.64 110.895 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.968 -1.015 . . . . 1.2 110.57 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 109.589 -1.404 . . . . 1.62 109.589 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.651 ' HB3' ' HB ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.77 -60.64 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.36 -1.082 . . . . 1.04 108.088 179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -146.53 -39.49 0.21 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 118.906 -1.118 . . . . 0.76 112.741 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.69 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.211 -0.996 . . . . 0.73 112.307 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.682 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.92 -1.55 22.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.495 -0.753 . . . . 1.06 110.074 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -37.13 -41.72 0.82 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.321 -0.862 . . . . 0.58 112.133 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 5' ' ' LEU . 43.8 Cg_endo -66.79 -16.06 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.844 0.623 . . . . 0.55 110.871 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -98.54 -25.5 14.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.853 -1.154 . . . . 0.87 109.629 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HB ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -64.8 -30.05 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.295 -1.002 . . . . 0.53 108.295 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.629 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.6 pt -86.36 19.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 118.578 -1.249 . . . . 1.09 108.494 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.2 t -50.76 -41.22 56.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.922 -1.111 . . . . 0.62 108.97 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.589 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -65.28 -59.18 10.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 0.42 109.545 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.14 29.19 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.311 1.164 . . . . 0.33 112.205 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.98 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.555 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 1.38 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.831 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.35 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.831 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.43 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.52 106.035 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 1.14 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.72 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 1.08 109.406 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.49 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.3 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 45.0 t -97.19 -25.12 15.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.69 109.888 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.12 -22.6 24.02 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.988 -1.07 . . . . 0.45 110.012 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.05 -43.38 5.51 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.644 0.735 . . . . 1.29 109.29 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.66 -35.52 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.72 -0.613 . . . . 0.38 111.023 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -91.8 -58.52 2.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.775 -1.203 . . . . 0.35 110.428 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.7 t -71.06 -17.27 62.61 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.887 -1.133 . . . . 0.62 110.857 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.19 -64.3 0.57 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.512 -1.435 . . . . 0.54 109.512 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.03 -5.96 87.22 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.475 -1.014 . . . . 0.57 111.092 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.46 31.35 17.15 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.222 -1.164 . . . . 0.81 111.127 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.823 -1.084 . . . . 0.65 110.199 179.631 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.878 0 N-CA-C 109.73 -1.348 . . . . 1.25 109.73 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.62 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.54 -59.68 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.081 -1.081 . . . . 0.88 108.081 179.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.666 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.6 p90 -146.29 -39.35 0.22 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.101 -1.04 . . . . 0.77 112.527 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.44 -54.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 1.19 112.296 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.666 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.0 pp -110.62 -0.78 17.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.491 -0.755 . . . . 0.95 110.412 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.672 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.54 -40.67 1.04 Allowed Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 119.46 -0.896 . . . . 0.5 112.065 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.672 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 44.9 Cg_endo -68.92 -14.66 39.15 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 CA-C-N 118.909 0.646 . . . . 0.51 110.728 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.599 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.37 -26.47 13.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.902 -1.124 . . . . 0.63 109.751 179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.477 ' HB ' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -67.06 -30.91 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.758 -1.201 . . . . 0.34 107.758 178.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 2.6 pt -88.74 19.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 118.696 -1.201 . . . . 0.38 108.611 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 6.1 p -54.5 -32.11 57.3 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.762 -1.211 . . . . 0.33 108.9 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.528 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.2 t -85.77 -54.74 0.41 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.435 -0.791 . . . . 0.51 110.446 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.573 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 53.1 Cg_endo -80.61 13.94 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.027 1.151 . . . . 0.37 113.025 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.84 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.7 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.827 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.39 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.827 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.44 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.48 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 1.15 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.46 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.8 109.389 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.49 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.21 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 22.3 m -97.48 -24.84 15.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.26 109.556 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.04 -21.0 26.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.012 -1.055 . . . . 0.83 109.738 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 -45.95 5.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.756 0.789 . . . . 1.42 108.919 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.2 t -83.81 -45.0 13.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.78 -0.575 . . . . 0.32 110.749 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -81.93 -50.98 8.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.834 . . . . 0.3 110.72 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -87.58 25.34 1.48 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.984 -1.072 . . . . 0.61 110.624 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.06 -60.13 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.72 -1.352 . . . . 0.5 109.72 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . -90.21 32.01 5.13 Favored Glycine 0 N--CA 1.5 2.963 0 O-C-N 121.412 -1.052 . . . . 0.55 111.041 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 4.4 tt0 69.07 -58.75 0.49 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.523 -0.987 . . . . 0.96 112.583 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 117.636 -1.173 . . . . 0.89 111.386 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 N-CA-C 109.706 -1.358 . . . . 1.62 109.706 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.694 ' N ' HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.99 -60.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.033 -1.099 . . . . 0.98 108.033 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.725 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 38.3 p90 -145.52 -37.42 0.27 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 118.612 -1.235 . . . . 0.78 113.011 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.05 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.986 -1.071 . . . . 1.08 112.428 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.725 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -123.95 -0.47 8.44 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.262 -0.899 . . . . 0.55 110.747 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.779 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -42.69 -33.5 0.69 Allowed Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 118.961 -1.095 . . . . 1.44 111.956 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.1 Cg_endo -91.41 0.01 4.64 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 O-C-N 122.558 0.768 . . . . 0.66 111.672 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 5.2 mppt? -106.65 -37.57 6.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.708 -1.245 . . . . 0.53 109.892 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.631 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -61.69 -33.34 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.87 108.487 178.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.624 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 18.9 pt -84.29 20.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 118.621 -1.232 . . . . 1.07 108.455 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.6 t -50.59 -41.79 55.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.843 -1.161 . . . . 0.58 108.998 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -65.36 -58.92 10.74 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.337 -0.852 . . . . 0.65 109.641 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.39 27.85 0.58 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.039 1.159 . . . . 0.3 112.313 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.69 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 1.03 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.822 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.43 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.822 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.54 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 1.25 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 1.12 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.43 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 1.17 108.951 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 1.12 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.38 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 28' ' ' SER . 4.2 p -96.05 -25.56 15.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.51 109.565 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.17 -22.14 21.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.232 -0.918 . . . . 1.1 110.08 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -103.18 -40.41 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.529 0.681 . . . . 1.14 109.502 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -90.7 -35.47 14.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.51 110.941 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -95.09 -49.95 5.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.101 -0.999 . . . . 0.75 110.368 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 18.8 m -85.58 -9.37 57.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.56 110.973 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.4 -72.19 0.72 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.201 -1.56 . . . . 0.5 109.201 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -70.82 -59.51 5.11 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.871 -1.292 . . . . 0.54 109.871 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 0.8 OUTLIER 66.79 -59.9 0.36 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.761 -0.847 . . . . 0.96 111.058 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.57 -0.729 . . . . 1.15 111.604 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.808 0 N-CA-C 109.729 -1.348 . . . . 1.07 109.729 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.601 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.98 -59.55 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.36 -1.083 . . . . 0.76 108.092 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.71 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.9 p90 -146.47 -38.5 0.22 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.09 -1.044 . . . . 0.49 112.483 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.66 -53.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.1 112.351 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.71 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.75 -1.71 16.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.413 -0.805 . . . . 1.08 110.457 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.698 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.04 -40.48 1.14 Allowed Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.211 -0.931 . . . . 0.46 112.16 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.698 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 47.1 Cg_endo -70.37 -12.41 31.68 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 CA-C-N 118.946 0.659 . . . . 0.41 110.931 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.591 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.33 -32.91 11.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.873 -1.142 . . . . 0.42 109.702 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -64.04 -30.4 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.43 108.495 178.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.2 pt -85.14 17.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.524 -1.27 . . . . 1.14 108.989 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 29.6 t -50.97 -40.02 56.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.42 108.968 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.613 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -70.02 -58.03 5.63 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.41 109.795 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.616 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.6 Cg_endo -83.09 30.19 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.047 1.164 . . . . 0.33 112.373 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 1.2 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.555 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.59 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.36 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.837 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.37 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 1.21 106.22 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.7 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.31 107.088 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 1.07 109.124 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.84 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.25 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 47.6 m -98.83 -22.51 15.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.31 109.48 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.62 -21.66 20.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.145 -0.972 . . . . 0.42 109.484 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -36.45 7.92 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.422 0.63 . . . . 1.33 109.67 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.1 -19.96 17.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.728 . . . . 0.39 111.652 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -111.32 -61.11 1.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.92 -1.113 . . . . 0.71 111.072 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -94.35 24.12 4.69 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.086 -1.009 . . . . 0.48 111.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.65 37.0 0.78 Allowed Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.987 -1.245 . . . . 0.34 109.987 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.69 68.85 0.15 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.749 -1.74 . . . . 0.37 108.749 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 33' ' ' GLU . 1.2 pm0 -94.05 -171.0 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.676 -0.896 . . . . 0.5 111.03 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 pm0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.621 -1.18 . . . . 0.57 111.061 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.488 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 120.458 0.108 . . . . 0.31 112.361 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 0.40999999999999998 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.64000000000000001 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.28000000000000003 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.28999999999999998 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.667 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.37 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 0.40000000000000002 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.29999999999999999 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.28000000000000003 109.048 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.34000000000000002 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.26000000000000001 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.32000000000000001 109.126 178.202 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.2 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.486 0.119 . . . . 0.27000000000000002 112.371 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 0.34000000000000002 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 0.78000000000000003 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.23999999999999999 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.23999999999999999 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.37 106.388 175.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 0.35999999999999999 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.27000000000000002 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.28999999999999998 109.177 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.33000000000000002 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.20000000000000001 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.55 178.474 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.2 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 120.548 0.145 . . . . 0.35999999999999999 112.274 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 0.53000000000000003 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 0.80000000000000004 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.872 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.34000000000000002 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.872 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.35999999999999999 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.53000000000000003 106.547 175.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.31 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.41999999999999998 109.093 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 0.51000000000000001 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.31 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.46000000000000002 109.614 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.607 0.17 . . . . 0.33000000000000002 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 0.44 111.21 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.58999999999999997 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.33000000000000002 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.37 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 0.93999999999999995 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.38 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.306 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.34000000000000002 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.20000000000000001 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.31 109.528 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.49 1.31 0 N-CA-C 112.433 0.128 . . . . 0.34000000000000002 112.433 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 0.48999999999999999 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 0.97999999999999998 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.40999999999999998 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 0.98999999999999999 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 0.45000000000000001 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.46999999999999997 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.39000000000000001 109.356 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 0.40999999999999998 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.22 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.32000000000000001 109.234 178.375 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.533 0.139 . . . . 0.29999999999999999 112.341 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.47999999999999998 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.66000000000000003 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.856 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.29999999999999999 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.856 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.34000000000000002 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 0.70999999999999996 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 0.90000000000000002 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.37 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 0.40999999999999998 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.27000000000000002 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.38 109.797 178.349 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.539 0.169 . . . . 0.37 112.539 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.40000000000000002 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 0.76000000000000001 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.874 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.38 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.874 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.39000000000000001 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 0.46000000000000002 106.423 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 0.5 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.40999999999999998 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.45000000000000001 109.013 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.48999999999999999 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.33000000000000002 107.654 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.47999999999999998 109.736 178.377 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.622 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.6 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 112.925 0.317 . . . . 0.35999999999999999 112.925 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 0.38 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.48999999999999999 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.26000000000000001 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.23999999999999999 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 0.93000000000000005 106.065 175.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.35999999999999999 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.29999999999999999 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.28999999999999998 108.854 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.32000000000000001 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.22 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.32000000000000001 109.264 178.198 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.682 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo . . . . . 0 N--CA 1.493 1.492 0 N-CA-C 113.021 0.354 . . . . 0.28999999999999998 113.021 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.44 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.57999999999999996 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.849 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.20999999999999999 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.849 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.20999999999999999 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.31 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.40000000000000002 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.41999999999999998 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 109.253 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.26000000000000001 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.19 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.34999999999999998 109.926 178.438 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-O 120.58 0.158 . . . . 0.22 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.31 111.256 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 0.88 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.764 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.22 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.764 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.23000000000000001 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.35999999999999999 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 0.54000000000000004 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.26000000000000001 109.361 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.29999999999999999 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.22 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.32000000000000001 109.547 178.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.9 Cg_endo . . . . . 0 N--CA 1.493 1.483 0 N-CA-C 112.623 0.201 . . . . 0.38 112.623 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 0.55000000000000004 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 0.93000000000000005 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.864 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.37 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.864 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.40999999999999998 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.51000000000000001 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 0.45000000000000001 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.41999999999999998 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 0.39000000000000001 109.457 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.42999999999999999 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.23999999999999999 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.27000000000000002 109.641 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.491 1.329 0 CA-C-O 120.791 0.246 . . . . 0.34000000000000002 112.03 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 0.44 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.62 111.43 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.40999999999999998 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.8 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.42999999999999999 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.0 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 0.48999999999999999 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.40999999999999998 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 0.46999999999999997 109.076 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 0.46000000000000002 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.28000000000000003 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.34000000000000002 109.23 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.8 Cg_endo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 120.567 0.153 . . . . 0.20999999999999999 112.314 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.32000000000000001 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.27000000000000002 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.32000000000000001 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.29999999999999999 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.29999999999999999 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.20999999999999999 109.436 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 0.28000000000000003 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.16 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.19 109.926 178.626 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.593 0.164 . . . . 0.32000000000000001 112.071 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 0.47999999999999998 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.75 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.34000000000000002 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.805 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.37 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 0.56999999999999995 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 0.46000000000000002 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.29999999999999999 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 0.41999999999999998 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.28000000000000003 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.40999999999999998 109.308 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.526 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.485 0.119 . . . . 0.25 112.39 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.35999999999999999 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.56999999999999995 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.862 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.20000000000000001 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.862 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.20999999999999999 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.32000000000000001 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.48999999999999999 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.20000000000000001 109.23 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 0.20000000000000001 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.14999999999999999 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.38 109.712 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 N-CA-C 112.423 0.124 . . . . 0.31 112.423 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 0.42999999999999999 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 0.29999999999999999 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 0.81000000000000005 106.045 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 0.39000000000000001 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.32000000000000001 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 0.39000000000000001 108.77 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.40000000000000002 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.26000000000000001 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.31 109.419 178.24 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.519 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.608 0.17 . . . . 0.31 112.205 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.38 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 0.94999999999999996 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.29999999999999999 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.34000000000000002 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.40000000000000002 106.035 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 0.45000000000000001 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.64000000000000001 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 0.33000000000000002 109.406 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.31 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.27000000000000002 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.51000000000000001 109.888 178.326 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.1 Cg_endo . . . . . 0 N--CA 1.493 1.477 0 N-CA-C 113.025 0.356 . . . . 0.37 113.025 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.38 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.58999999999999997 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.34000000000000002 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.34999999999999998 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.38 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 0.44 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.40000000000000002 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.31 109.389 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.34000000000000002 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.19 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.23000000000000001 109.556 178.291 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.488 0.12 . . . . 0.26000000000000001 112.313 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.46000000000000002 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.34000000000000002 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.40000000000000002 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 0.59999999999999998 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 0.46999999999999997 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 0.46000000000000002 108.951 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 0.46999999999999997 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.34000000000000002 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.47999999999999998 109.565 178.277 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.6 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.54 0.142 . . . . 0.32000000000000001 112.373 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 0.53000000000000003 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.28999999999999998 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.27000000000000002 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 0.46000000000000002 106.22 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.1399999999999999 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.28000000000000003 107.088 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 0.28999999999999998 109.124 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.33000000000000002 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.23000000000000001 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.26000000000000001 109.48 178.461 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.828 0 N-CA-C 109.688 -1.365 . . . . 0.40999999999999998 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.938 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.31 -59.48 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.402 -1.057 . . . . 0.53000000000000003 108.271 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.23 -38.58 0.2 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 118.574 -1.251 . . . . 0.45000000000000001 113.17 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.251 . . -173.13 -48.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.40999999999999998 112.139 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.649 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.4 pp -116.26 -3.9 11.94 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.207 -0.933 . . . . 0.34000000000000002 110.874 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.053 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.9 -41.68 2.25 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 118.969 -1.092 . . . . 0.29999999999999999 111.576 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.053 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.8 Cg_endo -69.99 -15.07 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 122.468 0.72 . . . . 0.27000000000000002 111.254 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.6 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.51 -30.55 11.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.744 -1.222 . . . . 0.41999999999999998 109.326 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.62 -30.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.295 -1.002 . . . . 0.31 108.295 178.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.4 pt -83.88 17.39 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.21 0 C-N-CA 118.597 -1.241 . . . . 0.26000000000000001 109.194 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.692 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.3 t -50.27 -41.54 50.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.639 -1.288 . . . . 0.32000000000000001 108.874 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -67.75 -58.51 8.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.388 -0.82 . . . . 0.32000000000000001 109.871 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.23 26.81 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.97 1.113 . . . . 0.31 112.361 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 0.40999999999999998 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.64000000000000001 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.28000000000000003 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.28999999999999998 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.667 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.37 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 0.40000000000000002 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.29999999999999999 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.28000000000000003 109.048 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.34000000000000002 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.26000000000000001 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.9 m -99.68 -27.53 13.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.32000000000000001 109.126 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -84.66 -20.47 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.355 -0.84 . . . . 0.34999999999999998 110.323 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.03 -40.64 4.43 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.735 -0.603 . . . . 0.84999999999999998 109.751 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -82.09 -35.75 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.56000000000000005 109.51 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -94.3 -59.72 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.692 -1.225 . . . . 0.40000000000000002 107.692 178.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -80.24 170.9 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.676 -1.231 . . . . 0.31 107.676 176.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.64 -61.54 2.42 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 108.753 -1.739 . . . . 0.42999999999999999 108.753 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -75.51 -44.71 20.53 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.893 -1.683 . . . . 0.46999999999999997 108.893 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 19.2 mt-30 60.06 54.35 4.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.804 -0.821 . . . . 0.70999999999999996 110.858 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.87 -1.062 . . . . 0.87 110.359 179.692 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.809 0 N-CA-C 109.642 -1.383 . . . . 0.62 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.793 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -150.92 -61.18 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 107.975 -1.12 . . . . 0.54000000000000004 107.975 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.703 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 40.4 p90 -145.71 -38.19 0.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 118.547 -1.261 . . . . 0.34000000000000002 113.045 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.73 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.013 -1.054 . . . . 0.28999999999999998 112.399 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.703 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -124.22 -0.17 8.33 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.29999999999999999 110.625 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.793 HG21 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -42.67 -33.49 0.69 Allowed Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.155 -1.018 . . . . 0.35999999999999999 112.093 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.9 Cg_endo -92.4 -0.14 4.01 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 O-C-N 122.469 0.72 . . . . 0.29999999999999999 111.667 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 7.0 mppt? -107.23 -32.28 7.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.618 -1.301 . . . . 0.37 110.197 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.652 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.33 -30.22 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.35999999999999999 108.429 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 pt -83.28 16.9 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 C-N-CA 118.809 -1.156 . . . . 0.28999999999999998 109.095 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.718 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.1 t -50.18 -40.74 47.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.74 -1.225 . . . . 0.26000000000000001 108.982 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -69.27 -58.76 5.71 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.27000000000000002 109.698 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -82.71 29.49 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.258 1.136 . . . . 0.27000000000000002 112.371 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 0.34000000000000002 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 0.78000000000000003 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.23999999999999999 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.23999999999999999 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.37 106.388 175.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 0.35999999999999999 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.27000000000000002 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.28999999999999998 109.177 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.33000000000000002 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.20000000000000001 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 39.0 m -98.36 -23.37 15.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.55 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.29 -23.37 21.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.134 -0.979 . . . . 0.27000000000000002 109.469 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.35 -45.25 5.65 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.757 0.789 . . . . 0.79000000000000004 109.105 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -86.57 -36.21 19.03 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.759 -0.588 . . . . 0.27000000000000002 111.123 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.654 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -90.87 -25.19 19.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.346 -1.472 . . . . 0.34000000000000002 111.563 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 t -117.0 21.95 12.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.44 111.056 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.45 -57.2 0.01 OUTLIER Glycine 0 N--CA 1.5 2.941 0 C-N-CA 119.678 -1.249 . . . . 0.51000000000000001 110.407 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -162.76 97.96 0.16 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 108.755 -1.738 . . . . 0.37 108.755 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 124.54 20.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.659 -0.906 . . . . 0.60999999999999999 111.524 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.339 -0.838 . . . . 0.67000000000000004 110.402 179.243 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.765 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.589 -1.404 . . . . 0.85999999999999999 109.589 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.815 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.47 -60.65 0.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.336 -1.097 . . . . 1.05 108.106 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.684 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.0 p90 -146.65 -39.05 0.21 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.914 -1.114 . . . . 0.72999999999999998 112.687 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.56 -55.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.999 -1.063 . . . . 0.63 112.26 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.684 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.18 -1.28 23.81 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.537 -0.727 . . . . 0.51000000000000001 110.035 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.12 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.43 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.502 2.175 0 O-C-N 121.346 -0.846 . . . . 0.55000000000000004 112.229 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.12 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.5 Cg_endo -67.1 -16.87 50.2 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 122.31 0.637 . . . . 0.58999999999999997 111.021 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -97.9 -24.49 15.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.872 -1.143 . . . . 0.81999999999999995 109.569 178.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -29.63 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.368 -0.975 . . . . 0.34999999999999998 108.368 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 12.6 pt -85.37 18.37 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 C-N-CA 118.49 -1.284 . . . . 0.52000000000000002 108.73 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.723 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 8.5 t -50.61 -41.9 55.41 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.801 -1.187 . . . . 0.35999999999999999 108.968 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.641 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.56 -58.06 7.56 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.31 109.828 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -82.81 30.38 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.986 1.124 . . . . 0.35999999999999999 112.274 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 0.53000000000000003 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.723 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 0.80000000000000004 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.872 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.34000000000000002 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.872 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.35999999999999999 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.53000000000000003 106.547 175.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.31 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.41999999999999998 109.093 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 0.51000000000000001 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.31 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 11.2 t -97.47 -23.79 15.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.46000000000000002 109.614 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -91.4 -21.32 21.04 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.168 -0.958 . . . . 0.44 109.675 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.22 -37.33 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.738 -0.601 . . . . 0.81000000000000005 109.557 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -96.1 -23.84 16.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.686 -0.634 . . . . 0.46999999999999997 111.454 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -109.17 -66.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.077 -1.014 . . . . 0.44 110.592 -179.04 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 28.0 t -87.5 51.39 2.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.951 -1.093 . . . . 0.52000000000000002 109.818 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.7 -73.31 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.279 -1.129 . . . . 0.41999999999999998 110.279 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.98 77.16 0.25 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.229 -1.148 . . . . 0.52000000000000002 110.229 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -35.05 28.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.418 -1.048 . . . . 1.3600000000000001 110.778 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 118.428 -0.796 . . . . 0.95999999999999996 110.937 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.814 0 N-CA-C 109.819 -1.312 . . . . 1.0700000000000001 109.819 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.881 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.55 -59.95 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.364 -1.08 . . . . 1.1200000000000001 108.165 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.3 p90 -146.76 -38.92 0.21 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.066 -1.054 . . . . 0.87 112.684 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.26 -54.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 112.304 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.656 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -108.39 -1.88 19.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.454 -0.779 . . . . 0.39000000000000001 110.406 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.041 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -37.69 -41.57 0.99 Allowed Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.339 -0.944 . . . . 0.63 111.915 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.041 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.6 Cg_endo -67.61 -15.01 43.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 122.392 0.68 . . . . 0.63 111.027 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -97.28 -29.29 13.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.865 -1.147 . . . . 0.68999999999999995 109.733 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -68.02 -33.35 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.864 -1.162 . . . . 0.46999999999999997 107.864 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.605 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.6 pt -87.48 19.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.719 -1.192 . . . . 0.31 108.268 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 26.6 t -51.37 -39.63 57.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.007 -1.058 . . . . 0.45000000000000001 108.788 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.54 -59.53 5.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.906 . . . . 0.41999999999999998 109.534 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.0 Cg_endo -84.31 37.36 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.058 1.172 . . . . 0.33000000000000002 111.928 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 0.44 111.21 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.748 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.58999999999999997 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.33000000000000002 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.37 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 0.93999999999999995 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.38 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.306 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.34000000000000002 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.20000000000000001 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' SER . 34.3 m -97.99 -23.15 15.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.31 109.528 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 -21.3 23.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.818 -1.176 . . . . 0.38 109.558 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.42 -44.87 5.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.852 -0.796 . . . . 0.88 108.852 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 t -82.98 -40.62 19.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.71 -0.619 . . . . 0.34000000000000002 110.559 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -91.69 -62.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.44 111.037 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 t -71.97 -10.24 59.5 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.912 -1.117 . . . . 0.56999999999999995 111.404 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.02 36.72 3.44 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.077 -1.209 . . . . 0.51000000000000001 110.077 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 157.19 -47.21 0.47 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.104 -1.199 . . . . 0.56000000000000005 110.104 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.9 OUTLIER 76.71 140.23 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.493 0.663 . . . . 0.68999999999999995 110.789 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.95 -1.024 . . . . 0.63 110.687 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.525 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.913 0 N-CA-C 109.725 -1.35 . . . . 0.80000000000000004 109.725 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.935 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.77 -60.12 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.359 -1.083 . . . . 0.93999999999999995 108.198 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.667 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.28 -38.8 0.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 118.595 -1.242 . . . . 0.71999999999999997 113.194 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.75 -48.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.979 -1.076 . . . . 0.54000000000000004 112.039 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.9 pp -116.56 -3.6 11.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.206 -0.934 . . . . 0.41999999999999998 110.911 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.043 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.13 -41.75 2.49 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 118.929 -1.108 . . . . 0.40999999999999998 111.592 179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.043 ' HD3' HG23 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -70.23 -15.11 35.25 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.499 0.736 . . . . 0.46000000000000002 111.323 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.591 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.0 mppt? -100.72 -30.76 11.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.669 -1.27 . . . . 0.53000000000000003 109.228 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.57 -30.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.415 -0.957 . . . . 0.40000000000000002 108.415 178.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.609 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.7 pt -83.87 18.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 C-N-CA 118.562 -1.255 . . . . 0.29999999999999999 109.145 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.695 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 4.5 t -50.55 -41.14 53.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.702 -1.249 . . . . 0.48999999999999999 108.831 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.69 -59.05 7.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.41999999999999998 109.915 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.4 Cg_endo -82.87 27.18 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 O-C-N 123.283 1.149 . . . . 0.34000000000000002 112.433 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 0.48999999999999999 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.695 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 0.97999999999999998 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.40999999999999998 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 0.98999999999999999 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 0.45000000000000001 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.46999999999999997 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.39000000000000001 109.356 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 0.40999999999999998 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.22 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' SER . 28.6 m -96.74 -27.43 14.75 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.32000000000000001 109.234 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -86.49 -25.0 25.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.065 -1.022 . . . . 0.44 110.194 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.58 -47.66 4.57 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.386 -0.598 . . . . 1.02 109.386 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -78.44 -37.87 42.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.655 -0.653 . . . . 0.40999999999999998 111.34 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -83.91 0.86 46.07 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.725 -1.235 . . . . 0.47999999999999998 111.015 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -90.34 -42.47 10.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.081 -1.012 . . . . 0.56999999999999995 110.364 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.28 54.77 0.75 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.275 -1.13 . . . . 0.70999999999999996 110.275 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 -59.46 3.93 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.206 -1.173 . . . . 0.73999999999999999 110.395 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' C ' ' HA ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -158.16 -169.55 2.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.574 -0.957 . . . . 0.68999999999999995 110.561 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.87 -1.062 . . . . 0.68000000000000005 110.555 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 109.595 -1.402 . . . . 0.65000000000000002 109.595 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.951 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.05 -59.49 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.352 -1.087 . . . . 0.62 108.277 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.623 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -147.02 -38.81 0.2 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.548 -1.261 . . . . 0.47999999999999998 113.153 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.253 . . -172.99 -47.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.071 . . . . 0.41999999999999998 112.096 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.623 ' HG ' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 pp -116.7 -4.27 11.67 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.12 -0.988 . . . . 0.40999999999999998 110.856 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.031 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.8 -41.81 2.24 Favored Pre-proline 0 N--CA 1.501 2.093 0 C-N-CA 119.06 -1.056 . . . . 0.34999999999999998 111.674 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.031 ' HD3' HG23 ' A' ' 6' ' ' ILE . 45.3 Cg_endo -69.28 -14.26 37.29 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 122.405 0.687 . . . . 0.28999999999999998 111.256 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.64 -31.59 10.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.853 -1.154 . . . . 0.38 109.446 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.63 -30.55 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.329 -0.989 . . . . 0.34999999999999998 108.329 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.615 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.7 pt -84.19 17.56 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 118.596 -1.242 . . . . 0.28999999999999998 109.248 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.644 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 7.0 t -50.19 -40.67 47.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.731 -1.23 . . . . 0.34000000000000002 108.964 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.602 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.81 -58.94 7.32 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 109.795 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.08 27.2 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.286 1.151 . . . . 0.29999999999999999 112.341 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.47999999999999998 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.66000000000000003 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.856 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.29999999999999999 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.856 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.34000000000000002 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 0.70999999999999996 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 0.90000000000000002 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.37 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 0.40999999999999998 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.27000000000000002 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 28' ' ' SER . 9.1 p -97.63 -23.64 15.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.38 109.797 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -91.74 -17.3 25.61 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.159 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -107.4 -48.17 3.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.021 -1.104 . . . . 0.63 108.021 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -76.89 -42.14 40.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.745 -0.597 . . . . 0.46999999999999997 109.434 178.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -93.54 40.57 1.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.945 -1.097 . . . . 0.38 108.972 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 88.4 p -102.22 -70.81 0.74 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.581 -0.7 . . . . 0.42999999999999999 110.981 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -122.62 51.64 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.523 -1.431 . . . . 0.66000000000000003 109.523 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.84 47.82 30.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 108.778 -1.729 . . . . 0.68000000000000005 108.778 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -113.98 36.37 3.72 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.642 -0.916 . . . . 1.46 110.517 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.174 -0.954 . . . . 0.83999999999999997 110.419 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.909 0 N-CA-C 109.602 -1.399 . . . . 0.63 109.602 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.933 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.21 -59.93 0.08 Allowed 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.285 -1.127 . . . . 0.81000000000000005 108.183 179.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.8 p90 -147.41 -39.16 0.19 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 118.54 -1.264 . . . . 0.60999999999999999 113.259 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.47 -47.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.56000000000000005 112.104 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.8 pp -116.79 -3.51 11.69 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.194 -0.942 . . . . 0.44 110.816 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.017 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.41 -41.63 2.66 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 118.903 -1.119 . . . . 0.34999999999999998 111.553 179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.017 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.2 Cg_endo -70.1 -14.92 35.59 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 122.456 0.714 . . . . 0.34999999999999998 111.198 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.595 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.9 mppt? -101.75 -30.02 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 109.293 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.74 -30.41 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.405 -0.961 . . . . 0.34000000000000002 108.405 178.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.8 pt -84.05 18.82 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 C-N-CA 118.553 -1.259 . . . . 0.26000000000000001 108.964 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 10.1 t -50.96 -41.15 58.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.685 -1.259 . . . . 0.40999999999999998 108.889 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.606 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.79 -58.46 6.68 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.803 . . . . 0.46000000000000002 110.026 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.616 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.4 Cg_endo -82.83 25.92 0.66 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.01 1.14 . . . . 0.37 112.539 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.40000000000000002 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.746 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 0.76000000000000001 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.874 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.38 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.874 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.39000000000000001 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 0.46000000000000002 106.423 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 0.5 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.40999999999999998 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.45000000000000001 109.013 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.48999999999999999 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.33000000000000002 107.654 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 6.2 t -97.44 -20.32 17.85 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.47999999999999998 109.736 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.74 -20.99 19.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.08 -1.012 . . . . 0.46000000000000002 109.463 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -34.43 9.26 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.37 111.109 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -113.32 39.95 2.48 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.846 -1.159 . . . . 0.46999999999999997 110.942 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -139.14 -48.39 0.49 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.193 -0.942 . . . . 0.62 110.606 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.4 54.93 0.62 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.839 -1.704 . . . . 0.89000000000000001 108.839 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.78 59.88 0.34 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.423 -1.871 . . . . 0.79000000000000004 108.423 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.5 tt0 -51.49 137.46 24.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.881 -0.776 . . . . 0.77000000000000002 111.247 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.316 -0.85 . . . . 1.03 110.482 179.619 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.785 0 N-CA-C 109.748 -1.341 . . . . 0.56000000000000005 109.748 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.909 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.0 -59.82 0.08 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.333 -1.098 . . . . 0.56999999999999995 108.177 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.712 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -145.98 -39.52 0.23 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.09 -1.044 . . . . 0.41999999999999998 112.446 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.41 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.34999999999999998 112.349 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.712 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.89 -1.05 16.63 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.457 -0.777 . . . . 0.28000000000000003 110.445 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.015 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.66 -40.7 1.07 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 119.414 -0.914 . . . . 0.27000000000000002 112.181 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.015 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.7 Cg_endo -68.26 -14.38 40.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.326 0.645 . . . . 0.28000000000000003 110.774 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.15 -27.05 13.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.869 -1.144 . . . . 0.39000000000000001 109.896 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.522 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -67.19 -31.09 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.964 -1.124 . . . . 0.29999999999999999 107.964 178.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.747 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 2.9 pt -88.97 20.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.716 -1.194 . . . . 0.20000000000000001 108.626 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.589 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.0 p -54.32 -32.45 56.65 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.852 -1.155 . . . . 0.28999999999999998 108.721 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -85.5 -55.56 0.4 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.356 -0.84 . . . . 0.34999999999999998 110.363 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.6 Cg_endo -81.3 20.88 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.952 1.101 . . . . 0.35999999999999999 112.925 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 0.38 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.48999999999999999 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.26000000000000001 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.23999999999999999 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 0.93000000000000005 106.065 175.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.35999999999999999 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.29999999999999999 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.28999999999999998 108.854 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.32000000000000001 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.22 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 p -97.55 -22.01 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.32000000000000001 109.264 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.22 -23.88 19.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.92 -1.113 . . . . 0.34000000000000002 109.347 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -35.58 9.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.369 0.604 . . . . 0.52000000000000002 109.651 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.701 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -98.7 -31.43 11.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.679 -0.638 . . . . 0.25 111.712 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.652 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -86.53 3.72 43.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.919 -1.113 . . . . 0.32000000000000001 110.835 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -96.25 -46.29 6.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.904 . . . . 0.41999999999999998 109.911 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.33 28.1 4.11 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.512 -1.435 . . . . 0.52000000000000002 109.512 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 55.83 26.49 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.625 -1.39 . . . . 0.47999999999999998 109.625 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 52.0 tp60 -63.84 -64.59 0.85 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -1.053 . . . . 0.55000000000000004 110.431 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.918 -1.039 . . . . 0.56999999999999995 110.613 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 109.692 -1.363 . . . . 0.5 109.692 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.913 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.74 -59.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.086 -1.079 . . . . 0.45000000000000001 108.086 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.693 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.9 p90 -146.45 -39.04 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.143 -1.023 . . . . 0.38 112.362 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 -54.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.341 -0.944 . . . . 0.29999999999999999 112.397 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.3 pp -110.51 -0.96 17.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.418 -0.802 . . . . 0.20999999999999999 110.375 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.035 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.42 -40.81 1.03 Allowed Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.245 -0.909 . . . . 0.26000000000000001 112.126 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.035 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.4 Cg_endo -68.53 -15.03 41.07 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 122.309 0.636 . . . . 0.27000000000000002 110.731 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -99.92 -26.22 14.07 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.35999999999999999 109.645 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.522 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -66.84 -30.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.93 -1.137 . . . . 0.28999999999999998 107.93 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 14' ' ' LEU . 2.6 pt -88.37 19.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 118.738 -1.185 . . . . 0.22 108.754 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 6.4 p -54.4 -32.12 56.54 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.808 -1.183 . . . . 0.25 108.827 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -85.43 -55.66 0.4 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.31 110.278 178.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.682 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo -81.6 19.55 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.08 1.187 . . . . 0.28999999999999998 113.021 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.44 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.57999999999999996 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.849 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.20999999999999999 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.849 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.20999999999999999 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.31 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.40000000000000002 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.41999999999999998 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 109.253 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.26000000000000001 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.19 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.3 t -97.94 -25.63 14.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.34999999999999998 109.926 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.76 21.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.799 -1.188 . . . . 0.23000000000000001 109.841 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 tp -101.16 -45.2 5.45 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.269 -0.641 . . . . 0.41999999999999998 109.269 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -82.4 -33.65 28.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.26000000000000001 111.304 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -86.25 15.12 5.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.28000000000000003 110.567 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -105.88 -57.64 2.02 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.351 -0.843 . . . . 0.29999999999999999 109.329 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.59 15.08 3.88 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.384 -1.086 . . . . 0.40000000000000002 110.384 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.15 -53.62 0.77 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.86 -1.296 . . . . 0.28999999999999998 109.86 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 1.4 tt0 -166.96 -51.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.343 -1.092 . . . . 0.53000000000000003 111.06 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.119 -0.944 . . . . 0.40000000000000002 111.036 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.573 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.932 0 N-CA-C 109.708 -1.357 . . . . 0.56000000000000005 109.708 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.917 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.63 -59.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.304 -1.115 . . . . 0.62 108.296 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.676 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -146.89 -39.14 0.21 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 118.61 -1.236 . . . . 0.34999999999999998 113.364 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.5 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.979 -1.075 . . . . 0.34999999999999998 112.306 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.9 pp -116.54 -4.43 11.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.257 -0.902 . . . . 0.40000000000000002 110.845 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.055 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.97 -40.83 1.86 Allowed Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 118.994 -1.083 . . . . 0.28999999999999998 111.963 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.055 ' HD3' HG23 ' A' ' 6' ' ' ILE . 55.1 Cg_endo -75.18 -11.45 21.16 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 122.335 0.65 . . . . 0.28999999999999998 111.634 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.5 mppt? -99.98 -36.66 9.3 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.684 -1.26 . . . . 0.40000000000000002 110.536 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.684 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -63.4 -33.12 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.143 -0.973 . . . . 0.28999999999999998 108.502 178.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.6 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 8.5 pt -84.36 19.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.5 -1.28 . . . . 0.23000000000000001 108.527 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.8 t -51.02 -41.25 59.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.938 -1.101 . . . . 0.27000000000000002 108.959 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.685 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -66.86 -59.41 7.83 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.31 109.629 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.6 Cg_endo -83.64 35.85 0.58 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.022 1.148 . . . . 0.22 112.047 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.31 111.256 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.709 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 0.88 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.764 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.22 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.764 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.23000000000000001 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.35999999999999999 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 0.54000000000000004 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.26000000000000001 109.361 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.29999999999999999 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.22 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 44.3 t -97.46 -23.57 16.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.32000000000000001 109.547 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -88.23 -22.6 23.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.27000000000000002 109.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -101.03 -46.22 5.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.849 -0.797 . . . . 0.55000000000000004 108.849 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.628 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 2.3 t -81.62 -39.23 24.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.27000000000000002 110.719 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -94.27 -61.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 0.26000000000000001 110.974 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 8.2 t -73.9 -6.31 46.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.984 -1.072 . . . . 0.45000000000000001 111.767 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.9 -71.52 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.658 -1.377 . . . . 0.39000000000000001 109.658 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -77.96 -14.19 82.58 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.435 -1.038 . . . . 0.37 111.178 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 18.3 mm-40 59.77 38.14 21.71 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.408 -1.054 . . . . 0.63 111.085 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 118.89 -0.576 . . . . 0.56999999999999995 111.308 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 109.656 -1.378 . . . . 0.53000000000000003 109.656 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.941 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.89 -59.66 0.06 Allowed 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.277 -1.131 . . . . 0.83999999999999997 108.217 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.5 p90 -147.09 -38.96 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.632 -1.227 . . . . 0.64000000000000001 113.096 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.52 -48.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.57999999999999996 112.129 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.9 pp -116.6 -3.4 11.8 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.167 -0.958 . . . . 0.44 110.848 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.079 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.16 -41.7 2.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 C-N-CA 118.916 -1.114 . . . . 0.34000000000000002 111.56 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.079 ' HD3' HG23 ' A' ' 6' ' ' ILE . 48.4 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.444 0.707 . . . . 0.33000000000000002 111.305 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -101.21 -30.46 11.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.82 -1.175 . . . . 0.52000000000000002 109.343 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.98 -30.22 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.406 -0.961 . . . . 0.28000000000000003 108.406 178.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.3 pt -84.33 18.4 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.297 0 C-N-CA 118.536 -1.265 . . . . 0.29999999999999999 108.931 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.1 t -50.6 -42.89 56.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.709 -1.244 . . . . 0.37 109.012 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.605 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -66.94 -58.37 9.57 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.842 . . . . 0.82999999999999996 109.992 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.9 Cg_endo -81.99 24.54 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.091 1.194 . . . . 0.38 112.623 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 0.55000000000000004 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.709 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 0.93000000000000005 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.864 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.37 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.864 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.40999999999999998 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.51000000000000001 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 0.45000000000000001 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.41999999999999998 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 0.39000000000000001 109.457 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.42999999999999999 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.23999999999999999 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.4 m -96.9 -24.85 15.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.27000000000000002 109.641 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.54 -22.05 21.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.39000000000000001 110.305 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.87 -42.04 5.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.327 -0.62 . . . . 0.77000000000000002 109.327 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -87.05 -27.27 23.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.762 -0.586 . . . . 0.42999999999999999 111.061 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -107.36 -56.46 2.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.923 -1.11 . . . . 0.34999999999999998 110.208 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 11.0 m -86.55 41.31 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.45000000000000001 110.428 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.59 -75.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.818 -1.313 . . . . 0.57999999999999996 109.818 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.94 72.96 0.22 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.656 -1.377 . . . . 0.54000000000000004 109.656 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -98.87 -57.85 2.08 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.985 . . . . 0.68000000000000005 111.057 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.865 -1.064 . . . . 0.92000000000000004 110.514 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.667 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.83 0 N-CA-C 109.734 -1.346 . . . . 1.02 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.828 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.49 -60.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.394 -1.063 . . . . 0.95999999999999996 108.151 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.705 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.4 p90 -146.54 -39.19 0.21 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.929 -1.108 . . . . 0.85999999999999999 112.665 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.61 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.096 -1.002 . . . . 0.66000000000000003 112.272 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.705 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -107.29 -1.42 21.72 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.409 -0.807 . . . . 0.48999999999999999 110.205 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.093 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.85 -41.86 0.77 Allowed Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 121.316 -0.865 . . . . 0.51000000000000001 112.09 179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.093 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.9 Cg_endo -67.34 -16.8 48.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 122.307 0.635 . . . . 0.56999999999999995 110.907 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -95.3 -25.99 16.1 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.935 -1.103 . . . . 0.68999999999999995 109.669 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -70.19 -33.99 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.775 -1.194 . . . . 0.41999999999999998 107.775 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.747 HD12 ' HG ' ' A' ' 14' ' ' LEU . 3.3 pt -90.7 18.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 118.978 -1.089 . . . . 0.31 108.385 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 27.4 p -55.23 -32.89 62.64 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.017 -1.052 . . . . 0.37 108.765 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.675 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -86.89 -55.05 0.37 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.57999999999999996 109.567 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -84.49 44.22 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.159 1.24 . . . . 0.34000000000000002 112.03 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 0.44 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.62 111.43 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.40999999999999998 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.8 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.42999999999999999 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.0 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 0.48999999999999999 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.40999999999999998 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 0.46999999999999997 109.076 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 0.46000000000000002 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.28000000000000003 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 50.4 m -95.34 -24.67 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.34000000000000002 109.23 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -91.24 -23.43 20.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 0.48999999999999999 110.084 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 -42.28 6.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.702 0.763 . . . . 0.72999999999999998 109.278 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -89.57 -34.01 16.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.715 -0.616 . . . . 0.35999999999999999 111.331 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.699 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -90.75 -41.21 11.39 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.681 -1.262 . . . . 0.44 110.843 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -83.92 -36.86 22.99 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.95 -1.094 . . . . 0.63 110.278 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -62.11 1.18 Allowed Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.589 -1.404 . . . . 0.68999999999999995 109.589 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.61 -13.68 74.73 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.446 -1.032 . . . . 0.62 110.833 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 64.37 30.75 13.14 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.436 -1.038 . . . . 0.85999999999999999 111.175 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.423 -0.798 . . . . 0.73999999999999999 110.237 179.612 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.893 0 N-CA-C 109.689 -1.365 . . . . 0.59999999999999998 109.689 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.797 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.12 -60.74 0.22 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.95 -1.13 . . . . 0.48999999999999999 107.95 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.783 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 39.3 p90 -146.47 -38.21 0.23 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 118.405 -1.318 . . . . 0.32000000000000001 113.237 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . . . -172.54 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.953 -1.092 . . . . 0.25 112.509 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 9' ' ' ILE . 3.7 pp -125.61 -1.42 7.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.35 -0.844 . . . . 0.29999999999999999 110.699 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.797 HG21 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -42.5 -33.89 0.73 Allowed Pre-proline 0 N--CA 1.496 1.85 0 C-N-CA 119.213 -0.995 . . . . 0.32000000000000001 111.969 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.0 Cg_endo -94.27 6.43 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 O-C-N 122.58 0.779 . . . . 0.23999999999999999 111.403 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 8.9 mtpt -110.27 -39.63 4.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.667 -1.27 . . . . 0.31 110.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 5' ' ' LEU . 2.2 pp -60.22 -28.96 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.015 -1.053 . . . . 0.32000000000000001 109.385 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.877 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.1 pp -92.31 17.69 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 118.062 -1.455 . . . . 0.22 109.452 177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 12.0 t -50.63 -41.3 54.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.864 -1.148 . . . . 0.28999999999999998 108.843 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.603 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -65.19 -59.99 8.76 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.452 -0.78 . . . . 0.33000000000000002 109.559 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 54.8 Cg_endo -83.39 32.66 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.995 1.13 . . . . 0.20999999999999999 112.314 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.719 ' CB ' HD13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.32000000000000001 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.611 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.27000000000000002 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.32000000000000001 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.29999999999999999 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.29999999999999999 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.20999999999999999 109.436 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 0.28000000000000003 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.16 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 28' ' ' SER . 18.8 m -95.35 -24.46 16.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.19 109.926 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.66 -15.92 24.83 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 0.20999999999999999 110.395 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -107.78 -36.24 6.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.459 -0.776 . . . . 0.48999999999999999 108.932 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -97.19 -30.18 13.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.23000000000000001 111.053 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -106.98 24.48 12.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.134 . . . . 0.28000000000000003 112.333 -178.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.4 p -114.51 -47.98 2.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.038 -1.039 . . . . 0.32000000000000001 110.205 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.35 55.26 4.22 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.62 -1.392 . . . . 0.39000000000000001 109.62 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . 138.26 -27.8 2.73 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.35999999999999999 109.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 75.6 138.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.653 0.739 . . . . 0.40000000000000002 111.307 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.949 -1.024 . . . . 0.51000000000000001 109.964 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.728 -1.349 . . . . 0.81000000000000005 109.728 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.939 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.35 -60.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.33 -1.1 . . . . 0.91000000000000003 108.249 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.675 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.0 p90 -146.81 -39.2 0.21 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.633 -1.227 . . . . 0.75 113.192 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.55 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.58999999999999997 112.155 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.675 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -117.31 -4.28 11.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.104 -0.998 . . . . 0.46999999999999997 110.721 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.042 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.58 -41.87 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 118.992 -1.083 . . . . 0.39000000000000001 111.74 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.042 ' HD3' HG23 ' A' ' 6' ' ' ILE . 46.1 Cg_endo -69.69 -15.22 37.24 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 122.481 0.727 . . . . 0.46000000000000002 111.264 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -99.33 -32.0 11.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.76 -1.212 . . . . 0.41999999999999998 109.623 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.607 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -61.84 -31.58 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.117 -1.068 . . . . 0.44 108.117 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HG ' ' A' ' 14' ' ' LEU . 7.0 pt -84.21 18.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 118.666 -1.214 . . . . 0.38 109.143 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.691 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 28.7 t -51.54 -40.73 60.23 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.77 -1.206 . . . . 0.37 108.831 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -70.13 -57.96 5.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.40000000000000002 109.507 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.7 Cg_endo -84.28 39.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.101 1.201 . . . . 0.32000000000000001 112.071 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 0.47999999999999998 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.691 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.75 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.34000000000000002 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.805 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.37 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 0.56999999999999995 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 0.46000000000000002 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.29999999999999999 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 0.41999999999999998 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.28000000000000003 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.4 OUTLIER -99.85 -23.81 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.40999999999999998 109.308 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -87.65 -21.8 25.08 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.985 -1.072 . . . . 0.44 109.282 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.61 -44.43 5.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.113 -0.699 . . . . 0.51000000000000001 109.113 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.12 -43.24 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.73 -0.606 . . . . 0.33000000000000002 111.146 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -75.46 -10.47 59.48 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.797 -1.189 . . . . 0.46999999999999997 110.767 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 20.4 t -121.75 18.95 11.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.51000000000000001 110.52 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.76 57.05 0.03 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.148 -1.181 . . . . 0.40000000000000002 110.148 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.78 68.9 0.2 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.418 -1.473 . . . . 0.42999999999999999 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -93.44 -21.54 19.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.564 -0.962 . . . . 0.59999999999999998 110.728 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.502 -0.761 . . . . 0.94999999999999996 110.852 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.789 0 N-CA-C 109.704 -1.359 . . . . 0.66000000000000003 109.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.827 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.26 -60.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.155 -1.054 . . . . 0.64000000000000001 108.155 179.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.4 p90 -146.95 -39.35 0.2 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.764 -1.175 . . . . 0.35999999999999999 112.81 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.48 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.967 -1.083 . . . . 0.29999999999999999 112.228 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -105.84 -1.34 24.37 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.491 -0.756 . . . . 0.35999999999999999 109.988 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.085 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.45 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.503 2.179 0 C-N-CA 119.683 -0.807 . . . . 0.34000000000000002 112.183 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.085 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.2 Cg_endo -66.89 -17.01 51.41 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 122.276 0.619 . . . . 0.34000000000000002 110.837 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -99.06 -24.43 14.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.857 -1.152 . . . . 0.59999999999999998 109.457 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -29.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.314 -0.995 . . . . 0.33000000000000002 108.314 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -84.94 18.13 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.228 0 C-N-CA 118.659 -1.216 . . . . 0.28999999999999998 108.685 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.708 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.6 t -50.57 -40.53 52.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.721 -1.237 . . . . 0.28000000000000003 108.881 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -69.01 -58.44 6.38 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.29999999999999999 109.883 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.09 26.4 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.086 1.191 . . . . 0.25 112.39 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.35999999999999999 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.708 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.56999999999999995 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.862 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.20000000000000001 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.862 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.20999999999999999 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.32000000000000001 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.48999999999999999 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.20000000000000001 109.23 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 0.20000000000000001 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.14999999999999999 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.702 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 30.9 t -98.91 -25.71 14.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.38 109.712 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -86.65 -21.72 26.56 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.023 -1.048 . . . . 0.19 109.792 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.46 -42.51 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.209 -0.663 . . . . 0.29999999999999999 109.209 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -88.62 -42.82 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.20000000000000001 110.872 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.702 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -76.36 -13.8 60.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.719 -1.238 . . . . 0.28999999999999998 110.819 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 22.3 t -117.98 19.78 13.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.092 -1.005 . . . . 0.28000000000000003 110.489 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.42 53.53 0.02 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 110.487 -1.045 . . . . 0.28999999999999998 110.487 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.96 63.73 0.05 OUTLIER Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.965 -1.254 . . . . 0.23000000000000001 109.965 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.613 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 1.7 mm100 -76.06 -49.29 17.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.43 -1.041 . . . . 0.35999999999999999 110.287 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.838 -1.077 . . . . 0.53000000000000003 110.452 179.883 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.908 0 N-CA-C 109.636 -1.386 . . . . 0.53000000000000003 109.636 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.925 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.94 -59.85 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.343 -1.092 . . . . 0.57999999999999996 108.283 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.733 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.1 p90 -147.8 -38.96 0.19 Allowed 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 118.538 -1.265 . . . . 0.47999999999999998 113.233 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.45 -48.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.872 -1.143 . . . . 0.41999999999999998 112.187 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.7 pp -116.66 -3.37 11.77 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 110.762 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.038 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.32 -41.68 2.61 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 118.939 -1.105 . . . . 0.34999999999999998 111.552 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.038 ' HD3' HG23 ' A' ' 6' ' ' ILE . 46.6 Cg_endo -69.56 -15.21 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 122.521 0.748 . . . . 0.34000000000000002 111.308 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -100.96 -30.75 11.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.769 -1.207 . . . . 0.46000000000000002 109.34 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.651 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.78 -29.93 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 178.334 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.62 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -83.84 18.25 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.595 -1.242 . . . . 0.27000000000000002 108.973 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 5.0 t -50.8 -41.77 57.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.637 -1.289 . . . . 0.42999999999999999 108.94 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.26 -58.2 7.84 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.407 -0.808 . . . . 0.38 109.963 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.69 26.16 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 O-C-N 123.264 1.139 . . . . 0.31 112.423 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 0.42999999999999999 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.735 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 0.29999999999999999 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 0.81000000000000005 106.045 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 0.39000000000000001 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.32000000000000001 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 0.39000000000000001 108.77 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.40000000000000002 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.26000000000000001 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 5.1 p -97.56 -23.14 16.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.31 109.419 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.37 -19.79 22.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.048 -1.032 . . . . 0.39000000000000001 109.653 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.56 -33.15 8.19 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.487 0.66 . . . . 0.62 109.741 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -101.89 -29.07 12.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.38 111.728 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -92.54 -46.71 7.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 0.34000000000000002 111.146 -179.227 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.6 p -50.01 -28.95 7.7 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.381 -0.825 . . . . 0.46000000000000002 112.036 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.8 6.15 75.54 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.092 -1.005 . . . . 0.71999999999999997 111.422 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 119.58 -16.99 10.37 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.913 -1.346 . . . . 0.56999999999999995 110.46 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 63.2 tp60 67.16 -75.95 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.753 -0.851 . . . . 0.62 110.895 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.968 -1.015 . . . . 1.2 110.57 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.687 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 109.589 -1.404 . . . . 1.01 109.589 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.77 -60.64 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.36 -1.082 . . . . 0.93999999999999995 108.088 179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -146.53 -39.49 0.21 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 118.906 -1.118 . . . . 0.68000000000000005 112.741 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.69 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.211 -0.996 . . . . 0.5 112.307 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.685 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.92 -1.55 22.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.495 -0.753 . . . . 0.46999999999999997 110.074 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.133 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -37.13 -41.72 0.82 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.321 -0.862 . . . . 0.47999999999999998 112.133 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.133 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -66.79 -16.06 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.844 0.623 . . . . 0.48999999999999999 110.871 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -98.54 -25.5 14.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.853 -1.154 . . . . 0.72999999999999998 109.629 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -64.8 -30.05 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.63 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.6 pt -86.36 19.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 118.578 -1.249 . . . . 0.39000000000000001 108.494 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.2 t -50.76 -41.22 56.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.922 -1.111 . . . . 0.33000000000000002 108.97 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -65.28 -59.18 10.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 0.34999999999999998 109.545 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.14 29.19 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.311 1.164 . . . . 0.31 112.205 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.38 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 0.94999999999999996 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.29999999999999999 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.34000000000000002 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.40000000000000002 106.035 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 0.45000000000000001 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.64000000000000001 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 0.33000000000000002 109.406 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.31 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.27000000000000002 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.721 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 45.0 t -97.19 -25.12 15.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.51000000000000001 109.888 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -88.12 -22.6 24.02 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.988 -1.07 . . . . 0.34999999999999998 110.012 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.05 -43.38 5.51 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.644 0.735 . . . . 0.67000000000000004 109.29 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.66 -35.52 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.72 -0.613 . . . . 0.37 111.023 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -91.8 -58.52 2.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.775 -1.203 . . . . 0.34999999999999998 110.428 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.7 t -71.06 -17.27 62.61 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.887 -1.133 . . . . 0.53000000000000003 110.857 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.19 -64.3 0.57 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.512 -1.435 . . . . 0.54000000000000004 109.512 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.03 -5.96 87.22 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.475 -1.014 . . . . 0.51000000000000001 111.092 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.46 31.35 17.15 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.222 -1.164 . . . . 0.78000000000000003 111.127 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.823 -1.084 . . . . 0.65000000000000002 110.199 179.631 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.878 0 N-CA-C 109.73 -1.348 . . . . 0.82999999999999996 109.73 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.919 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.54 -59.68 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.081 -1.081 . . . . 0.78000000000000003 108.081 179.502 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.666 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.6 p90 -146.29 -39.35 0.22 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.101 -1.04 . . . . 0.70999999999999996 112.527 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.44 -54.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.54000000000000004 112.296 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.673 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 2.0 pp -110.62 -0.78 17.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.491 -0.755 . . . . 0.35999999999999999 110.412 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.009 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.54 -40.67 1.04 Allowed Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 119.46 -0.896 . . . . 0.40000000000000002 112.065 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.009 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.9 Cg_endo -68.92 -14.66 39.15 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 CA-C-N 118.909 0.646 . . . . 0.45000000000000001 110.728 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.37 -26.47 13.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.902 -1.124 . . . . 0.56999999999999995 109.751 179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -67.06 -30.91 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.758 -1.201 . . . . 0.26000000000000001 107.758 178.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 14' ' ' LEU . 2.6 pt -88.74 19.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 118.696 -1.201 . . . . 0.27000000000000002 108.611 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.1 p -54.5 -32.11 57.3 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.762 -1.211 . . . . 0.33000000000000002 108.9 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.544 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.2 t -85.77 -54.74 0.41 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.435 -0.791 . . . . 0.35999999999999999 110.446 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.1 Cg_endo -80.61 13.94 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.027 1.151 . . . . 0.37 113.025 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.38 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.58999999999999997 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.34000000000000002 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.34999999999999998 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.38 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 0.44 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.40000000000000002 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.31 109.389 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.34000000000000002 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.19 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 22.3 m -97.48 -24.84 15.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.23000000000000001 109.556 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -87.04 -21.0 26.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.012 -1.055 . . . . 0.34000000000000002 109.738 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 -45.95 5.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.756 0.789 . . . . 0.82999999999999996 108.919 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.2 t -83.81 -45.0 13.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.78 -0.575 . . . . 0.29999999999999999 110.749 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -81.93 -50.98 8.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.834 . . . . 0.29999999999999999 110.72 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -87.58 25.34 1.48 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.984 -1.072 . . . . 0.51000000000000001 110.624 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.06 -60.13 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.72 -1.352 . . . . 0.5 109.72 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . -90.21 32.01 5.13 Favored Glycine 0 N--CA 1.5 2.963 0 O-C-N 121.412 -1.052 . . . . 0.5 111.041 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 4.4 tt0 69.07 -58.75 0.49 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.523 -0.987 . . . . 0.95999999999999996 112.583 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 117.636 -1.173 . . . . 0.72999999999999998 111.386 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 N-CA-C 109.706 -1.358 . . . . 0.98999999999999999 109.706 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.781 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.99 -60.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.033 -1.099 . . . . 0.89000000000000001 108.033 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.732 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 38.3 p90 -145.52 -37.42 0.27 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 118.612 -1.235 . . . . 0.70999999999999996 113.011 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . -175.05 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.986 -1.071 . . . . 0.56000000000000005 112.428 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.732 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -123.95 -0.47 8.44 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.262 -0.899 . . . . 0.46000000000000002 110.747 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.782 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -42.69 -33.5 0.69 Allowed Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 118.961 -1.095 . . . . 0.65000000000000002 111.956 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.1 Cg_endo -91.41 0.01 4.64 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 O-C-N 122.558 0.768 . . . . 0.58999999999999997 111.672 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 5.2 mppt? -106.65 -37.57 6.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.708 -1.245 . . . . 0.44 109.892 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -61.69 -33.34 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.41999999999999998 108.487 178.408 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 18.9 pt -84.29 20.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 118.621 -1.232 . . . . 0.40999999999999998 108.455 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.666 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.6 t -50.59 -41.79 55.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.843 -1.161 . . . . 0.44 108.998 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.655 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -65.36 -58.92 10.74 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.337 -0.852 . . . . 0.35999999999999999 109.641 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.39 27.85 0.58 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.039 1.159 . . . . 0.26000000000000001 112.313 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.46000000000000002 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.34000000000000002 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.40000000000000002 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 0.59999999999999998 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 0.46999999999999997 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 0.46000000000000002 108.951 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 0.46999999999999997 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.34000000000000002 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.577 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.2 p -96.05 -25.56 15.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.47999999999999998 109.565 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.17 -22.14 21.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.232 -0.918 . . . . 0.42999999999999999 110.08 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -103.18 -40.41 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.529 0.681 . . . . 0.48999999999999999 109.502 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -90.7 -35.47 14.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.40999999999999998 110.941 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -95.09 -49.95 5.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.101 -0.999 . . . . 0.46000000000000002 110.368 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.554 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 18.8 m -85.58 -9.37 57.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.56000000000000005 110.973 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.4 -72.19 0.72 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.201 -1.56 . . . . 0.5 109.201 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -70.82 -59.51 5.11 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.871 -1.292 . . . . 0.5 109.871 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 66.79 -59.9 0.36 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.761 -0.847 . . . . 0.95999999999999996 111.058 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.57 -0.729 . . . . 1.1299999999999999 111.604 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.808 0 N-CA-C 109.729 -1.348 . . . . 0.45000000000000001 109.729 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.907 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.98 -59.55 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.36 -1.083 . . . . 0.66000000000000003 108.092 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.9 p90 -146.47 -38.5 0.22 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.09 -1.044 . . . . 0.46000000000000002 112.483 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.66 -53.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.39000000000000001 112.351 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.715 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.75 -1.71 16.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.413 -0.805 . . . . 0.28999999999999998 110.457 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.052 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.04 -40.48 1.14 Allowed Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.211 -0.931 . . . . 0.34999999999999998 112.16 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.052 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.1 Cg_endo -70.37 -12.41 31.68 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 CA-C-N 118.946 0.659 . . . . 0.35999999999999999 110.931 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.33 -32.91 11.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.873 -1.142 . . . . 0.34999999999999998 109.702 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -64.04 -30.4 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.31 108.495 178.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.2 pt -85.14 17.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.524 -1.27 . . . . 0.35999999999999999 108.989 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 29.6 t -50.97 -40.02 56.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.28999999999999998 108.968 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -70.02 -58.03 5.63 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.31 109.795 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.6 Cg_endo -83.09 30.19 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.047 1.164 . . . . 0.32000000000000001 112.373 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 0.53000000000000003 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.28999999999999998 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.27000000000000002 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 0.46000000000000002 106.22 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.1399999999999999 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.28000000000000003 107.088 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 0.28999999999999998 109.124 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.33000000000000002 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.23000000000000001 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 47.6 m -98.83 -22.51 15.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.26000000000000001 109.48 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.62 -21.66 20.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.145 -0.972 . . . . 0.28999999999999998 109.484 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -36.45 7.92 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.422 0.63 . . . . 0.69999999999999996 109.67 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.1 -19.96 17.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.728 . . . . 0.26000000000000001 111.652 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -111.32 -61.11 1.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.92 -1.113 . . . . 0.25 111.072 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -94.35 24.12 4.69 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.086 -1.009 . . . . 0.40999999999999998 111.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.65 37.0 0.78 Allowed Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.987 -1.245 . . . . 0.31 109.987 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.69 68.85 0.15 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.749 -1.74 . . . . 0.33000000000000002 108.749 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 33' ' ' GLU . 1.2 pm0 -94.05 -171.0 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.676 -0.896 . . . . 0.46000000000000002 111.03 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 pm0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.621 -1.18 . . . . 0.56999999999999995 111.061 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.488 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 120.458 0.108 . . . . 0.31 112.361 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 0.40999999999999998 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.64000000000000001 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.28000000000000003 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.28999999999999998 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.667 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.37 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 0.40000000000000002 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.29999999999999999 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.28000000000000003 109.048 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.34000000000000002 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.26000000000000001 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.32000000000000001 109.126 178.202 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.2 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.486 0.119 . . . . 0.27000000000000002 112.371 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 0.34000000000000002 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 0.78000000000000003 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.23999999999999999 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.23999999999999999 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.37 106.388 175.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 0.35999999999999999 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.27000000000000002 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.28999999999999998 109.177 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.33000000000000002 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.20000000000000001 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.55 178.474 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.2 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 120.548 0.145 . . . . 0.35999999999999999 112.274 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 0.53000000000000003 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 0.80000000000000004 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.872 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.34000000000000002 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.872 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.35999999999999999 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.53000000000000003 106.547 175.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.31 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.41999999999999998 109.093 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 0.51000000000000001 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.31 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.46000000000000002 109.614 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.607 0.17 . . . . 0.33000000000000002 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 0.44 111.21 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.58999999999999997 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.33000000000000002 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.37 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 0.93999999999999995 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.38 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.306 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.34000000000000002 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.20000000000000001 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.31 109.528 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.49 1.31 0 N-CA-C 112.433 0.128 . . . . 0.34000000000000002 112.433 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 0.48999999999999999 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 0.97999999999999998 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.40999999999999998 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 0.98999999999999999 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 0.45000000000000001 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.46999999999999997 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.39000000000000001 109.356 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 0.40999999999999998 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.22 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.32000000000000001 109.234 178.375 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.533 0.139 . . . . 0.29999999999999999 112.341 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.47999999999999998 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.66000000000000003 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.856 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.29999999999999999 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.856 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.34000000000000002 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 0.70999999999999996 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 0.90000000000000002 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.37 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 0.40999999999999998 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.27000000000000002 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.38 109.797 178.349 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.539 0.169 . . . . 0.37 112.539 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.40000000000000002 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 0.76000000000000001 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.874 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.38 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.874 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.39000000000000001 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 0.46000000000000002 106.423 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 0.5 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.40999999999999998 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.45000000000000001 109.013 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.48999999999999999 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.33000000000000002 107.654 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.47999999999999998 109.736 178.377 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.622 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.6 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 112.925 0.317 . . . . 0.35999999999999999 112.925 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 0.38 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.48999999999999999 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.26000000000000001 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.23999999999999999 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' O ' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 0.93000000000000005 106.065 175.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.35999999999999999 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.29999999999999999 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.28999999999999998 108.854 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.32000000000000001 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.22 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.32000000000000001 109.264 178.198 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.682 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo . . . . . 0 N--CA 1.493 1.492 0 N-CA-C 113.021 0.354 . . . . 0.28999999999999998 113.021 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.44 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.57999999999999996 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.849 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.20999999999999999 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.849 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.20999999999999999 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.31 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.40000000000000002 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.41999999999999998 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 109.253 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.26000000000000001 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.19 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.34999999999999998 109.926 178.438 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-O 120.58 0.158 . . . . 0.22 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.31 111.256 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 0.88 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.764 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.22 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.764 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.23000000000000001 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.35999999999999999 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 0.54000000000000004 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.26000000000000001 109.361 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.29999999999999999 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.22 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.32000000000000001 109.547 178.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.9 Cg_endo . . . . . 0 N--CA 1.493 1.483 0 N-CA-C 112.623 0.201 . . . . 0.38 112.623 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 0.55000000000000004 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 0.93000000000000005 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.864 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.37 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.864 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.40999999999999998 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.51000000000000001 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 0.45000000000000001 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.41999999999999998 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 0.39000000000000001 109.457 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.42999999999999999 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.23999999999999999 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.27000000000000002 109.641 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.491 1.329 0 CA-C-O 120.791 0.246 . . . . 0.34000000000000002 112.03 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 0.44 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.62 111.43 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.40999999999999998 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.8 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.42999999999999999 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.0 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 0.48999999999999999 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.40999999999999998 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 0.46999999999999997 109.076 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 0.46000000000000002 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.28000000000000003 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.34000000000000002 109.23 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.8 Cg_endo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 120.567 0.153 . . . . 0.20999999999999999 112.314 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.32000000000000001 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.27000000000000002 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.32000000000000001 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.29999999999999999 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.29999999999999999 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.20999999999999999 109.436 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 0.28000000000000003 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.16 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.19 109.926 178.626 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.593 0.164 . . . . 0.32000000000000001 112.071 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 0.47999999999999998 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.75 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.34000000000000002 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.805 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.37 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 0.56999999999999995 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 0.46000000000000002 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.29999999999999999 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 0.41999999999999998 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.28000000000000003 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.40999999999999998 109.308 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.526 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.485 0.119 . . . . 0.25 112.39 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.35999999999999999 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.56999999999999995 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.862 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.20000000000000001 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.862 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.20999999999999999 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.32000000000000001 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.48999999999999999 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.20000000000000001 109.23 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 0.20000000000000001 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.14999999999999999 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.38 109.712 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 N-CA-C 112.423 0.124 . . . . 0.31 112.423 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 0.42999999999999999 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 0.29999999999999999 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 0.81000000000000005 106.045 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 0.39000000000000001 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.32000000000000001 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 0.39000000000000001 108.77 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.40000000000000002 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.26000000000000001 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.31 109.419 178.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.519 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.5 Cg_endo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.608 0.17 . . . . 0.31 112.205 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.38 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 0.94999999999999996 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.29999999999999999 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.34000000000000002 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.40000000000000002 106.035 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 0.45000000000000001 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.64000000000000001 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 0.33000000000000002 109.406 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.31 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.27000000000000002 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.51000000000000001 109.888 178.326 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.1 Cg_endo . . . . . 0 N--CA 1.493 1.477 0 N-CA-C 113.025 0.356 . . . . 0.37 113.025 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.38 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.58999999999999997 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.34000000000000002 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.34999999999999998 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.38 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 0.44 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.40000000000000002 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.31 109.389 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.34000000000000002 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.19 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.23000000000000001 109.556 178.291 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.3 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.488 0.12 . . . . 0.26000000000000001 112.313 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.46000000000000002 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.34000000000000002 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.40000000000000002 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 0.59999999999999998 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 0.46999999999999997 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 0.46000000000000002 108.951 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 0.46999999999999997 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.34000000000000002 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.47999999999999998 109.565 178.277 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 55.6 Cg_endo . . . . . 0 N--CA 1.491 1.366 0 CA-C-O 120.54 0.142 . . . . 0.32000000000000001 112.373 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 0.53000000000000003 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.28999999999999998 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.27000000000000002 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 0.46000000000000002 106.22 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.1399999999999999 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.28000000000000003 107.088 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 0.28999999999999998 109.124 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.33000000000000002 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 22' ' ' VAL . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.23000000000000001 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.26000000000000001 109.48 178.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.828 0 N-CA-C 109.688 -1.365 . . . . 0.40999999999999998 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.938 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.31 -59.48 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.402 -1.057 . . . . 0.53000000000000003 108.271 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.23 -38.58 0.2 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 118.574 -1.251 . . . . 0.45000000000000001 113.17 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.251 . . -173.13 -48.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.40999999999999998 112.139 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.649 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.4 pp -116.26 -3.9 11.94 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.207 -0.933 . . . . 0.34000000000000002 110.874 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.053 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.9 -41.68 2.25 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 118.969 -1.092 . . . . 0.29999999999999999 111.576 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.053 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.8 Cg_endo -69.99 -15.07 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 122.468 0.72 . . . . 0.27000000000000002 111.254 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.6 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.51 -30.55 11.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.744 -1.222 . . . . 0.41999999999999998 109.326 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.62 -30.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.295 -1.002 . . . . 0.31 108.295 178.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.4 pt -83.88 17.39 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.21 0 C-N-CA 118.597 -1.241 . . . . 0.26000000000000001 109.194 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.692 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.3 t -50.27 -41.54 50.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.639 -1.288 . . . . 0.32000000000000001 108.874 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -67.75 -58.51 8.1 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.388 -0.82 . . . . 0.32000000000000001 109.871 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.23 26.81 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.97 1.113 . . . . 0.31 112.361 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -158.64 -59.17 0.07 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.466 -1.396 . . . . 0.40999999999999998 111.267 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.692 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -62.08 -46.36 89.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.313 -0.867 . . . . 0.64000000000000001 111.022 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.96 -20.11 1.24 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.335 -0.853 . . . . 0.28000000000000003 110.343 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -84.3 -45.1 13.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.458 -1.682 . . . . 0.28999999999999998 106.458 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.667 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -64.29 -29.74 70.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.995 -1.854 . . . . 0.37 105.995 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.3 mm? -74.78 -44.84 47.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.858 -1.164 . . . . 0.40000000000000002 107.858 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -60.32 -34.01 73.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.528 -1.656 . . . . 0.29999999999999999 106.528 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.61 -47.2 73.4 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.85 0.833 . . . . 0.28000000000000003 109.048 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -68.46 -40.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.466 0.651 . . . . 0.34000000000000002 109.344 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -56.96 -22.47 42.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 107.595 -2.202 . . . . 0.26000000000000001 107.595 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.9 m -99.68 -27.53 13.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -1.153 . . . . 0.32000000000000001 109.126 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -84.66 -20.47 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.355 -0.84 . . . . 0.34999999999999998 110.323 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.03 -40.64 4.43 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.735 -0.603 . . . . 0.84999999999999998 109.751 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.608 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -82.09 -35.75 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.56000000000000005 109.51 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -94.3 -59.72 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.692 -1.225 . . . . 0.40000000000000002 107.692 178.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -80.24 170.9 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.676 -1.231 . . . . 0.31 107.676 176.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.64 -61.54 2.42 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 108.753 -1.739 . . . . 0.42999999999999999 108.753 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -75.51 -44.71 20.53 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 108.893 -1.683 . . . . 0.46999999999999997 108.893 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 19.2 mt-30 60.06 54.35 4.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.804 -0.821 . . . . 0.70999999999999996 110.858 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.87 -1.062 . . . . 0.87 110.359 179.692 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.809 0 N-CA-C 109.642 -1.383 . . . . 0.62 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.793 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -150.92 -61.18 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 107.975 -1.12 . . . . 0.54000000000000004 107.975 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.703 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 40.4 p90 -145.71 -38.19 0.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 118.547 -1.261 . . . . 0.34000000000000002 113.045 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.73 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.013 -1.054 . . . . 0.28999999999999998 112.399 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.703 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -124.22 -0.17 8.33 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.29999999999999999 110.625 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.793 HG21 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -42.67 -33.49 0.69 Allowed Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.155 -1.018 . . . . 0.35999999999999999 112.093 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.9 Cg_endo -92.4 -0.14 4.01 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 O-C-N 122.469 0.72 . . . . 0.29999999999999999 111.667 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 7.0 mppt? -107.23 -32.28 7.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.618 -1.301 . . . . 0.37 110.197 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.652 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.33 -30.22 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.35999999999999999 108.429 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 pt -83.28 16.9 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.223 0 C-N-CA 118.809 -1.156 . . . . 0.28999999999999998 109.095 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.718 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.1 t -50.18 -40.74 47.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.74 -1.225 . . . . 0.26000000000000001 108.982 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -69.27 -58.76 5.71 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.27000000000000002 109.698 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -82.71 29.49 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.258 1.136 . . . . 0.27000000000000002 112.371 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -161.68 -60.19 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.602 -1.311 . . . . 0.34000000000000002 111.097 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.3 m-85 -61.48 -47.29 86.34 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.326 -0.859 . . . . 0.78000000000000003 110.923 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.03 -20.52 0.97 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.424 -0.797 . . . . 0.23999999999999999 110.404 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.93 -44.58 14.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.6 -1.63 . . . . 0.23999999999999999 106.6 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.8 -27.2 68.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.388 -1.708 . . . . 0.37 106.388 175.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 91.4 mt -77.08 -42.92 36.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.315 -1.365 . . . . 0.35999999999999999 107.315 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -60.38 -33.78 72.95 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.922 -1.51 . . . . 0.27000000000000002 106.922 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.1 -45.05 90.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.868 0.842 . . . . 0.28999999999999998 109.177 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.48 -40.79 77.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.042 -0.725 . . . . 0.33000000000000002 109.042 178.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.6 -18.96 46.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.675 -2.17 . . . . 0.20000000000000001 107.675 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 39.0 m -98.36 -23.37 15.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.152 -1.205 . . . . 0.23999999999999999 109.55 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.29 -23.37 21.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.134 -0.979 . . . . 0.27000000000000002 109.469 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.35 -45.25 5.65 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.757 0.789 . . . . 0.79000000000000004 109.105 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -86.57 -36.21 19.03 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.759 -0.588 . . . . 0.27000000000000002 111.123 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.654 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -90.87 -25.19 19.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.346 -1.472 . . . . 0.34000000000000002 111.563 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 t -117.0 21.95 12.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.44 111.056 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.45 -57.2 0.01 OUTLIER Glycine 0 N--CA 1.5 2.941 0 C-N-CA 119.678 -1.249 . . . . 0.51000000000000001 110.407 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -162.76 97.96 0.16 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 108.755 -1.738 . . . . 0.37 108.755 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 124.54 20.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.659 -0.906 . . . . 0.60999999999999999 111.524 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 118.339 -0.838 . . . . 0.67000000000000004 110.402 179.243 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.765 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.589 -1.404 . . . . 0.85999999999999999 109.589 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.815 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.47 -60.65 0.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.336 -1.097 . . . . 1.05 108.106 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.684 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.0 p90 -146.65 -39.05 0.21 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.914 -1.114 . . . . 0.72999999999999998 112.687 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.56 -55.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.999 -1.063 . . . . 0.63 112.26 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.684 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.18 -1.28 23.81 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.537 -0.727 . . . . 0.51000000000000001 110.035 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.12 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.43 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.502 2.175 0 O-C-N 121.346 -0.846 . . . . 0.55000000000000004 112.229 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.12 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.5 Cg_endo -67.1 -16.87 50.2 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 122.31 0.637 . . . . 0.58999999999999997 111.021 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -97.9 -24.49 15.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.872 -1.143 . . . . 0.81999999999999995 109.569 178.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -29.63 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.368 -0.975 . . . . 0.34999999999999998 108.368 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 12.6 pt -85.37 18.37 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 C-N-CA 118.49 -1.284 . . . . 0.52000000000000002 108.73 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.723 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 8.5 t -50.61 -41.9 55.41 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.801 -1.187 . . . . 0.35999999999999999 108.968 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.641 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.56 -58.06 7.56 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.752 . . . . 0.31 109.828 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -82.81 30.38 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.986 1.124 . . . . 0.35999999999999999 112.274 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -162.34 -60.72 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.65 -1.281 . . . . 0.53000000000000003 111.023 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.723 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -61.69 -47.86 83.39 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.382 -0.824 . . . . 0.80000000000000004 111.09 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.872 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -48.94 -20.69 0.54 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.331 -0.855 . . . . 0.34000000000000002 110.466 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.872 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.18 -44.85 13.55 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.667 -1.605 . . . . 0.35999999999999999 106.667 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.63 -26.69 67.19 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 106.547 -1.649 . . . . 0.53000000000000003 106.547 175.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -77.08 -42.94 36.2 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -60.98 -34.85 75.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.76 -1.57 . . . . 0.31 106.76 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.29 -44.18 97.11 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.946 0.879 . . . . 0.41999999999999998 109.093 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -71.84 -39.08 67.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.036 -0.728 . . . . 0.51000000000000001 109.036 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -58.64 -19.66 43.27 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 107.719 -2.152 . . . . 0.31 107.719 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 11.2 t -97.47 -23.79 15.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -1.088 . . . . 0.46000000000000002 109.614 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -91.4 -21.32 21.04 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.168 -0.958 . . . . 0.44 109.675 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.22 -37.33 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.738 -0.601 . . . . 0.81000000000000005 109.557 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -96.1 -23.84 16.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.686 -0.634 . . . . 0.46999999999999997 111.454 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -109.17 -66.62 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.077 -1.014 . . . . 0.44 110.592 -179.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 28.0 t -87.5 51.39 2.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.951 -1.093 . . . . 0.52000000000000002 109.818 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.7 -73.31 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.279 -1.129 . . . . 0.41999999999999998 110.279 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.98 77.16 0.25 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.229 -1.148 . . . . 0.52000000000000002 110.229 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -35.05 28.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.418 -1.048 . . . . 1.3600000000000001 110.778 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 118.428 -0.796 . . . . 0.95999999999999996 110.937 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.814 0 N-CA-C 109.819 -1.312 . . . . 1.0700000000000001 109.819 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.881 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.55 -59.95 0.07 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.364 -1.08 . . . . 1.1200000000000001 108.165 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.3 p90 -146.76 -38.92 0.21 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.066 -1.054 . . . . 0.87 112.684 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.26 -54.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 112.304 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.656 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -108.39 -1.88 19.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.454 -0.779 . . . . 0.39000000000000001 110.406 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.041 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -37.69 -41.57 0.99 Allowed Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.339 -0.944 . . . . 0.63 111.915 179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.041 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.6 Cg_endo -67.61 -15.01 43.87 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 122.392 0.68 . . . . 0.63 111.027 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -97.28 -29.29 13.63 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.865 -1.147 . . . . 0.68999999999999995 109.733 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -68.02 -33.35 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.864 -1.162 . . . . 0.46999999999999997 107.864 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.605 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.6 pt -87.48 19.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.719 -1.192 . . . . 0.31 108.268 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 26.6 t -51.37 -39.63 57.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.007 -1.058 . . . . 0.45000000000000001 108.788 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.674 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.54 -59.53 5.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.906 . . . . 0.41999999999999998 109.534 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.0 Cg_endo -84.31 37.36 0.62 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.058 1.172 . . . . 0.33000000000000002 111.928 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -168.53 -58.84 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.649 -1.282 . . . . 0.44 111.21 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.748 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.41 -47.08 73.17 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.259 -0.901 . . . . 0.58999999999999997 111.142 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -20.95 7.37 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.416 -0.914 . . . . 0.33000000000000002 109.623 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.27 -41.01 29.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.138 -1.801 . . . . 0.37 106.138 177.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -68.34 -35.0 77.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.302 -1.74 . . . . 0.93999999999999995 106.302 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 1.1 mm? -70.33 -43.42 70.3 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -60.03 -36.15 76.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.498 -1.667 . . . . 0.38 106.498 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.23 -47.29 71.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.306 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.22 -41.13 88.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.442 0.639 . . . . 0.34000000000000002 109.322 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -59.5 -22.22 56.01 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.512 -2.235 . . . . 0.20000000000000001 107.512 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' SER . 34.3 m -97.99 -23.15 15.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.976 . . . . 0.31 109.528 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 -21.3 23.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.818 -1.176 . . . . 0.38 109.558 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.42 -44.87 5.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.852 -0.796 . . . . 0.88 108.852 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 t -82.98 -40.62 19.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.71 -0.619 . . . . 0.34000000000000002 110.559 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -91.69 -62.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.44 111.037 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 t -71.97 -10.24 59.5 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.912 -1.117 . . . . 0.56999999999999995 111.404 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.02 36.72 3.44 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.077 -1.209 . . . . 0.51000000000000001 110.077 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 157.19 -47.21 0.47 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.104 -1.199 . . . . 0.56000000000000005 110.104 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.9 OUTLIER 76.71 140.23 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.493 0.663 . . . . 0.68999999999999995 110.789 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.95 -1.024 . . . . 0.63 110.687 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.525 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.913 0 N-CA-C 109.725 -1.35 . . . . 0.80000000000000004 109.725 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.935 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.77 -60.12 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.359 -1.083 . . . . 0.93999999999999995 108.198 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.667 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.7 p90 -147.28 -38.8 0.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 118.595 -1.242 . . . . 0.71999999999999997 113.194 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.75 -48.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.979 -1.076 . . . . 0.54000000000000004 112.039 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.9 pp -116.56 -3.6 11.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.206 -0.934 . . . . 0.41999999999999998 110.911 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.043 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.13 -41.75 2.49 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 118.929 -1.108 . . . . 0.40999999999999998 111.592 179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.043 ' HD3' HG23 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -70.23 -15.11 35.25 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.499 0.736 . . . . 0.46000000000000002 111.323 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.591 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.0 mppt? -100.72 -30.76 11.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.669 -1.27 . . . . 0.53000000000000003 109.228 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.57 -30.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.415 -0.957 . . . . 0.40000000000000002 108.415 178.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.609 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.7 pt -83.87 18.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 C-N-CA 118.562 -1.255 . . . . 0.29999999999999999 109.145 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.695 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 4.5 t -50.55 -41.14 53.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.702 -1.249 . . . . 0.48999999999999999 108.831 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.69 -59.05 7.31 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.41999999999999998 109.915 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.4 Cg_endo -82.87 27.18 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 O-C-N 123.283 1.149 . . . . 0.34000000000000002 112.433 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -158.65 -59.71 0.07 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.557 -1.339 . . . . 0.48999999999999999 111.219 -178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.695 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -60.51 -47.3 86.77 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.419 -0.801 . . . . 0.97999999999999998 111.193 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.78 -20.93 1.42 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.4 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.53 -44.63 14.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.563 -1.643 . . . . 0.40999999999999998 106.563 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -64.97 -28.66 69.67 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.049 -1.834 . . . . 0.98999999999999999 106.049 175.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.6 -44.98 48.08 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.633 -1.247 . . . . 0.45000000000000001 107.633 177.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 t -58.39 -35.25 71.73 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.343 -1.725 . . . . 0.46999999999999997 106.343 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.51 -48.67 66.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.745 0.783 . . . . 0.39000000000000001 109.356 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.69 -41.67 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.318 0.58 . . . . 0.40999999999999998 109.657 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.72 -22.61 53.81 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 107.462 -2.255 . . . . 0.22 107.462 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' SER . 28.6 m -96.74 -27.43 14.75 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.254 . . . . 0.32000000000000001 109.234 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -86.49 -25.0 25.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.065 -1.022 . . . . 0.44 110.194 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.58 -47.66 4.57 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.386 -0.598 . . . . 1.02 109.386 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -78.44 -37.87 42.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.655 -0.653 . . . . 0.40999999999999998 111.34 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -83.91 0.86 46.07 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.725 -1.235 . . . . 0.47999999999999998 111.015 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -90.34 -42.47 10.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.081 -1.012 . . . . 0.56999999999999995 110.364 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.28 54.77 0.75 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.275 -1.13 . . . . 0.70999999999999996 110.275 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.11 -59.46 3.93 Favored Glycine 0 N--CA 1.498 2.778 0 O-C-N 121.206 -1.173 . . . . 0.73999999999999999 110.395 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' C ' ' HA ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -158.16 -169.55 2.83 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.574 -0.957 . . . . 0.68999999999999995 110.561 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.135 0 CA-C-O 117.87 -1.062 . . . . 0.68000000000000005 110.555 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 109.595 -1.402 . . . . 0.65000000000000002 109.595 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.951 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.05 -59.49 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.352 -1.087 . . . . 0.62 108.277 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.623 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -147.02 -38.81 0.2 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.548 -1.261 . . . . 0.47999999999999998 113.153 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.253 . . -172.99 -47.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.987 -1.071 . . . . 0.41999999999999998 112.096 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.623 ' HG ' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 pp -116.7 -4.27 11.67 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.12 -0.988 . . . . 0.40999999999999998 110.856 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.031 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.8 -41.81 2.24 Favored Pre-proline 0 N--CA 1.501 2.093 0 C-N-CA 119.06 -1.056 . . . . 0.34999999999999998 111.674 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.031 ' HD3' HG23 ' A' ' 6' ' ' ILE . 45.3 Cg_endo -69.28 -14.26 37.29 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 122.405 0.687 . . . . 0.28999999999999998 111.256 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -101.64 -31.59 10.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.853 -1.154 . . . . 0.38 109.446 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -60.63 -30.55 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.329 -0.989 . . . . 0.34999999999999998 108.329 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.615 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.7 pt -84.19 17.56 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 118.596 -1.242 . . . . 0.28999999999999998 109.248 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.644 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 7.0 t -50.19 -40.67 47.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.731 -1.23 . . . . 0.34000000000000002 108.964 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.602 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -67.81 -58.94 7.32 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 109.795 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.615 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.08 27.2 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.286 1.151 . . . . 0.29999999999999999 112.341 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -157.79 -58.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.479 -1.388 . . . . 0.47999999999999998 111.104 -178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.06 -46.26 88.3 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.303 -0.873 . . . . 0.66000000000000003 111.092 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.856 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.16 -21.04 1.16 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.301 -0.874 . . . . 0.29999999999999999 110.33 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.856 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.68 -44.79 14.14 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.34000000000000002 106.639 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.13 -27.19 67.12 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.439 -1.689 . . . . 0.70999999999999996 106.439 175.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 31.5 mt -75.44 -44.35 44.82 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.049 -1.463 . . . . 0.90000000000000002 107.049 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 t -59.42 -37.52 78.26 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.396 -1.705 . . . . 0.44 106.396 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.71 77.99 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.563 0.696 . . . . 0.37 109.183 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.18 -39.54 85.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.397 0.618 . . . . 0.40999999999999998 109.335 178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.04 -22.93 50.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.596 -2.202 . . . . 0.27000000000000002 107.596 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 28' ' ' SER . 9.1 p -97.63 -23.64 15.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -1.17 . . . . 0.38 109.797 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -91.74 -17.3 25.61 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.159 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -107.4 -48.17 3.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.021 -1.104 . . . . 0.63 108.021 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -76.89 -42.14 40.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.745 -0.597 . . . . 0.46999999999999997 109.434 178.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -93.54 40.57 1.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.945 -1.097 . . . . 0.38 108.972 178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 88.4 p -102.22 -70.81 0.74 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.581 -0.7 . . . . 0.42999999999999999 110.981 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -122.62 51.64 0.79 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.523 -1.431 . . . . 0.66000000000000003 109.523 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.84 47.82 30.69 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 108.778 -1.729 . . . . 0.68000000000000005 108.778 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -113.98 36.37 3.72 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.642 -0.916 . . . . 1.46 110.517 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.174 -0.954 . . . . 0.83999999999999997 110.419 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.909 0 N-CA-C 109.602 -1.399 . . . . 0.63 109.602 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.933 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.21 -59.93 0.08 Allowed 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.285 -1.127 . . . . 0.81000000000000005 108.183 179.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.8 p90 -147.41 -39.16 0.19 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 118.54 -1.264 . . . . 0.60999999999999999 113.259 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.47 -47.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.56000000000000005 112.104 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.8 pp -116.79 -3.51 11.69 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.194 -0.942 . . . . 0.44 110.816 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.017 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.41 -41.63 2.66 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 118.903 -1.119 . . . . 0.34999999999999998 111.553 179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.017 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.2 Cg_endo -70.1 -14.92 35.59 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 122.456 0.714 . . . . 0.34999999999999998 111.198 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.595 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.9 mppt? -101.75 -30.02 11.55 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 109.293 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.74 -30.41 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.405 -0.961 . . . . 0.34000000000000002 108.405 178.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 5.8 pt -84.05 18.82 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 C-N-CA 118.553 -1.259 . . . . 0.26000000000000001 108.964 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 10.1 t -50.96 -41.15 58.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.685 -1.259 . . . . 0.40999999999999998 108.889 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.606 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -68.79 -58.46 6.68 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.803 . . . . 0.46000000000000002 110.026 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.616 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.4 Cg_endo -82.83 25.92 0.66 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.01 1.14 . . . . 0.37 112.539 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -158.82 -61.25 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.55 -1.344 . . . . 0.40000000000000002 111.234 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.746 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 2.5 m-85 -60.2 -47.65 85.06 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.474 -0.766 . . . . 0.76000000000000001 111.048 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.874 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.77 -20.53 0.86 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.378 -0.826 . . . . 0.38 110.621 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.874 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.01 -44.56 14.02 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.448 -1.686 . . . . 0.39000000000000001 106.448 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.36 -26.68 67.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.423 -1.695 . . . . 0.46000000000000002 106.423 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 16' ' ' LYS . 83.4 mt -76.42 -44.06 37.6 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.157 -1.424 . . . . 0.5 107.157 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -60.24 -34.56 73.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.909 -1.515 . . . . 0.40999999999999998 106.909 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.84 -44.55 95.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.936 0.874 . . . . 0.45000000000000001 109.013 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.53 -38.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.864 -0.791 . . . . 0.48999999999999999 108.864 178.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.0 -20.47 41.86 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 107.654 -2.179 . . . . 0.33000000000000002 107.654 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 6.2 t -97.44 -20.32 17.85 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.325 -1.103 . . . . 0.47999999999999998 109.736 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.74 -20.99 19.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.08 -1.012 . . . . 0.46000000000000002 109.463 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -34.43 9.26 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.641 -0.662 . . . . 0.37 111.109 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -113.32 39.95 2.48 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.846 -1.159 . . . . 0.46999999999999997 110.942 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -139.14 -48.39 0.49 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.193 -0.942 . . . . 0.62 110.606 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.4 54.93 0.62 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.839 -1.704 . . . . 0.89000000000000001 108.839 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.78 59.88 0.34 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.423 -1.871 . . . . 0.79000000000000004 108.423 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.5 tt0 -51.49 137.46 24.07 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.881 -0.776 . . . . 0.77000000000000002 111.247 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.316 -0.85 . . . . 1.03 110.482 179.619 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.785 0 N-CA-C 109.748 -1.341 . . . . 0.56000000000000005 109.748 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.909 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.0 -59.82 0.08 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.333 -1.098 . . . . 0.56999999999999995 108.177 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.712 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -145.98 -39.52 0.23 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.09 -1.044 . . . . 0.41999999999999998 112.446 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.41 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.34999999999999998 112.349 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.712 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.89 -1.05 16.63 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.457 -0.777 . . . . 0.28000000000000003 110.445 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.015 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.66 -40.7 1.07 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 119.414 -0.914 . . . . 0.27000000000000002 112.181 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.015 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.7 Cg_endo -68.26 -14.38 40.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.326 0.645 . . . . 0.28000000000000003 110.774 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.15 -27.05 13.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.869 -1.144 . . . . 0.39000000000000001 109.896 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.522 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -67.19 -31.09 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.964 -1.124 . . . . 0.29999999999999999 107.964 178.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.747 ' HB ' ' HB2' ' A' ' 14' ' ' LEU . 2.9 pt -88.97 20.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.716 -1.194 . . . . 0.20000000000000001 108.626 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.589 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.0 p -54.32 -32.45 56.65 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.852 -1.155 . . . . 0.28999999999999998 108.721 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -85.5 -55.56 0.4 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.356 -0.84 . . . . 0.34999999999999998 110.363 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 54.6 Cg_endo -81.3 20.88 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.952 1.101 . . . . 0.35999999999999999 112.925 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -153.62 -59.88 0.13 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.664 -1.272 . . . . 0.38 110.649 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.1 m-85 -59.28 -45.62 90.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.477 -0.764 . . . . 0.48999999999999999 110.726 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.25 -21.08 1.22 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.38 -0.825 . . . . 0.26000000000000001 110.589 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -84.68 -44.31 13.53 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.723 -1.584 . . . . 0.23999999999999999 106.723 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.76 -28.11 68.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.065 -1.828 . . . . 0.93000000000000005 106.065 175.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 4.6 mp -75.28 -44.76 43.93 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.388 -1.338 . . . . 0.35999999999999999 107.388 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -60.06 -34.95 74.13 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.686 -1.598 . . . . 0.29999999999999999 106.686 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.14 -46.41 81.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.854 -0.795 . . . . 0.28999999999999998 108.854 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.05 -40.87 86.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.716 -0.846 . . . . 0.32000000000000001 108.716 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.3 -18.92 44.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 107.802 -2.119 . . . . 0.22 107.802 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.652 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 p -97.55 -22.01 16.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -1.089 . . . . 0.32000000000000001 109.264 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.22 -23.88 19.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.92 -1.113 . . . . 0.34000000000000002 109.347 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -35.58 9.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.369 0.604 . . . . 0.52000000000000002 109.651 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.701 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -98.7 -31.43 11.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.679 -0.638 . . . . 0.25 111.712 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.652 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -86.53 3.72 43.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.919 -1.113 . . . . 0.32000000000000001 110.835 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -96.25 -46.29 6.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.904 . . . . 0.41999999999999998 109.911 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.33 28.1 4.11 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.512 -1.435 . . . . 0.52000000000000002 109.512 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 55.83 26.49 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.625 -1.39 . . . . 0.47999999999999998 109.625 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 27' ' ' SER . 52.0 tp60 -63.84 -64.59 0.85 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -1.053 . . . . 0.55000000000000004 110.431 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.918 -1.039 . . . . 0.56999999999999995 110.613 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.717 0 N-CA-C 109.692 -1.363 . . . . 0.5 109.692 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.913 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.74 -59.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.086 -1.079 . . . . 0.45000000000000001 108.086 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.693 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 32.9 p90 -146.45 -39.04 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.143 -1.023 . . . . 0.38 112.362 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 -54.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.341 -0.944 . . . . 0.29999999999999999 112.397 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.3 pp -110.51 -0.96 17.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.418 -0.802 . . . . 0.20999999999999999 110.375 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.035 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.42 -40.81 1.03 Allowed Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 121.245 -0.909 . . . . 0.26000000000000001 112.126 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.035 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.4 Cg_endo -68.53 -15.03 41.07 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 122.309 0.636 . . . . 0.27000000000000002 110.731 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -99.92 -26.22 14.07 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.35999999999999999 109.645 178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.522 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -66.84 -30.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.93 -1.137 . . . . 0.28999999999999998 107.93 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.718 HD12 ' HG ' ' A' ' 14' ' ' LEU . 2.6 pt -88.37 19.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 118.738 -1.185 . . . . 0.22 108.754 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 6.4 p -54.4 -32.12 56.54 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.808 -1.183 . . . . 0.25 108.827 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -85.43 -55.66 0.4 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.31 110.278 178.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.682 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.4 Cg_endo -81.6 19.55 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.08 1.187 . . . . 0.28999999999999998 113.021 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.718 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -151.46 -59.23 0.16 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.601 -1.312 . . . . 0.44 110.811 -179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -58.83 -45.82 89.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.357 -0.84 . . . . 0.57999999999999996 110.804 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.849 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.62 -21.75 1.7 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.464 -0.772 . . . . 0.20999999999999999 110.36 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.849 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -82.83 -44.28 15.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.502 -1.666 . . . . 0.20999999999999999 106.502 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -63.85 -30.14 71.26 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.74 -1.948 . . . . 0.31 105.74 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' LYS . 60.5 mt -72.44 -46.74 53.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.844 -1.169 . . . . 0.40000000000000002 107.844 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -58.52 -35.67 72.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.663 -1.606 . . . . 0.41999999999999998 106.663 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.56 74.83 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 109.253 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -65.74 -39.96 86.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 109.302 -0.629 . . . . 0.26000000000000001 109.302 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.13 -23.6 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 107.567 -2.213 . . . . 0.19 107.567 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.3 t -97.94 -25.63 14.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -1.167 . . . . 0.34999999999999998 109.926 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.76 21.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.799 -1.188 . . . . 0.23000000000000001 109.841 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 tp -101.16 -45.2 5.45 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.269 -0.641 . . . . 0.41999999999999998 109.269 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -82.4 -33.65 28.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.26000000000000001 111.304 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -86.25 15.12 5.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.861 -1.149 . . . . 0.28000000000000003 110.567 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -105.88 -57.64 2.02 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.351 -0.843 . . . . 0.29999999999999999 109.329 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.59 15.08 3.88 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.384 -1.086 . . . . 0.40000000000000002 110.384 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.15 -53.62 0.77 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.86 -1.296 . . . . 0.28999999999999998 109.86 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 1.4 tt0 -166.96 -51.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.343 -1.092 . . . . 0.53000000000000003 111.06 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.119 -0.944 . . . . 0.40000000000000002 111.036 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.573 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.932 0 N-CA-C 109.708 -1.357 . . . . 0.56000000000000005 109.708 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.917 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.63 -59.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.304 -1.115 . . . . 0.62 108.296 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.676 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.3 p90 -146.89 -39.14 0.21 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 118.61 -1.236 . . . . 0.34999999999999998 113.364 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . 0.252 . . -172.5 -48.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.979 -1.075 . . . . 0.34999999999999998 112.306 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.9 pp -116.54 -4.43 11.74 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.257 -0.902 . . . . 0.40000000000000002 110.845 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.055 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.97 -40.83 1.86 Allowed Pre-proline 0 N--CA 1.5 2.059 0 C-N-CA 118.994 -1.083 . . . . 0.28999999999999998 111.963 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.055 ' HD3' HG23 ' A' ' 6' ' ' ILE . 55.1 Cg_endo -75.18 -11.45 21.16 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 O-C-N 122.335 0.65 . . . . 0.28999999999999998 111.634 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.5 mppt? -99.98 -36.66 9.3 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.684 -1.26 . . . . 0.40000000000000002 110.536 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.684 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -63.4 -33.12 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.143 -0.973 . . . . 0.28999999999999998 108.502 178.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.6 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 8.5 pt -84.36 19.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.5 -1.28 . . . . 0.23000000000000001 108.527 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 13.8 t -51.02 -41.25 59.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.938 -1.101 . . . . 0.27000000000000002 108.959 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.685 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -66.86 -59.41 7.83 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.31 109.629 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.6 Cg_endo -83.64 35.85 0.58 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.022 1.148 . . . . 0.22 112.047 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -167.52 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.715 -1.241 . . . . 0.31 111.256 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.709 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -53.73 -46.54 70.86 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.307 -0.871 . . . . 0.88 111.024 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.764 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.17 -21.16 8.13 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.354 -0.938 . . . . 0.22 109.523 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.764 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -78.85 -40.51 32.43 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.12 -1.807 . . . . 0.23000000000000001 106.12 177.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -67.63 -35.78 79.54 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.211 -1.774 . . . . 0.35999999999999999 106.211 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 83.6 mt -68.9 -44.84 72.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.756 -1.202 . . . . 0.54000000000000004 107.756 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 t -60.11 -36.64 77.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.713 -1.588 . . . . 0.44 106.713 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.23 -46.6 79.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.711 0.767 . . . . 0.26000000000000001 109.361 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -66.13 -39.16 83.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.114 -0.699 . . . . 0.29999999999999999 109.114 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -57.78 -23.6 50.98 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 107.49 -2.244 . . . . 0.22 107.49 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 44.3 t -97.46 -23.57 16.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -1.138 . . . . 0.32000000000000001 109.547 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -88.23 -22.6 23.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.27000000000000002 109.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -101.03 -46.22 5.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.849 -0.797 . . . . 0.55000000000000004 108.849 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.628 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 2.3 t -81.62 -39.23 24.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.593 -0.692 . . . . 0.27000000000000002 110.719 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -94.27 -61.28 1.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 0.26000000000000001 110.974 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 8.2 t -73.9 -6.31 46.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.984 -1.072 . . . . 0.45000000000000001 111.767 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.9 -71.52 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.658 -1.377 . . . . 0.39000000000000001 109.658 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . -77.96 -14.19 82.58 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.435 -1.038 . . . . 0.37 111.178 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 18.3 mm-40 59.77 38.14 21.71 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.408 -1.054 . . . . 0.63 111.085 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 118.89 -0.576 . . . . 0.56999999999999995 111.308 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 109.656 -1.378 . . . . 0.53000000000000003 109.656 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.941 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -159.89 -59.66 0.06 Allowed 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.277 -1.131 . . . . 0.83999999999999997 108.217 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.5 p90 -147.09 -38.96 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 118.632 -1.227 . . . . 0.64000000000000001 113.096 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.52 -48.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.57999999999999996 112.129 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 9' ' ' ILE . 1.9 pp -116.6 -3.4 11.8 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.167 -0.958 . . . . 0.44 110.848 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.079 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.16 -41.7 2.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 C-N-CA 118.916 -1.114 . . . . 0.34000000000000002 111.56 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.079 ' HD3' HG23 ' A' ' 6' ' ' ILE . 48.4 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 O-C-N 122.444 0.707 . . . . 0.33000000000000002 111.305 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -101.21 -30.46 11.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.82 -1.175 . . . . 0.52000000000000002 109.343 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.98 -30.22 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.406 -0.961 . . . . 0.28000000000000003 108.406 178.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.602 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 6.3 pt -84.33 18.4 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.297 0 C-N-CA 118.536 -1.265 . . . . 0.29999999999999999 108.931 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.1 t -50.6 -42.89 56.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.709 -1.244 . . . . 0.37 109.012 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.605 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -66.94 -58.37 9.57 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.842 . . . . 0.82999999999999996 109.992 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.9 Cg_endo -81.99 24.54 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.091 1.194 . . . . 0.38 112.623 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -157.55 -59.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.541 -1.349 . . . . 0.55000000000000004 111.164 -178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.709 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.6 m-85 -60.47 -46.69 89.16 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.408 -0.808 . . . . 0.93000000000000005 110.95 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.864 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.18 -21.44 1.32 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.422 -0.799 . . . . 0.37 110.412 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.864 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.5 m -82.77 -44.73 15.23 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.474 -1.676 . . . . 0.40999999999999998 106.474 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -63.87 -29.44 70.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.009 -1.849 . . . . 0.51000000000000001 106.009 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 16' ' ' LYS . 87.2 mt -74.04 -46.02 45.97 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.958 -1.127 . . . . 0.45000000000000001 107.958 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 t -59.41 -34.8 72.91 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.796 -1.557 . . . . 0.41999999999999998 106.796 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.59 -46.3 76.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.83 0.824 . . . . 0.39000000000000001 109.457 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -68.87 -40.52 81.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.368 0.604 . . . . 0.42999999999999999 109.696 179.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.46 -22.93 53.06 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 107.672 -2.171 . . . . 0.23999999999999999 107.672 178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' SER . 16.4 m -96.9 -24.85 15.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -1.104 . . . . 0.27000000000000002 109.641 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.54 -22.05 21.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.39000000000000001 110.305 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.87 -42.04 5.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.327 -0.62 . . . . 0.77000000000000002 109.327 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -87.05 -27.27 23.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.762 -0.586 . . . . 0.42999999999999999 111.061 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -107.36 -56.46 2.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.923 -1.11 . . . . 0.34999999999999998 110.208 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 11.0 m -86.55 41.31 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.45000000000000001 110.428 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.59 -75.18 0.04 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.818 -1.313 . . . . 0.57999999999999996 109.818 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.94 72.96 0.22 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.656 -1.377 . . . . 0.54000000000000004 109.656 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -98.87 -57.85 2.08 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.985 . . . . 0.68000000000000005 111.057 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.865 -1.064 . . . . 0.92000000000000004 110.514 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.667 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.83 0 N-CA-C 109.734 -1.346 . . . . 1.02 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.828 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.49 -60.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.394 -1.063 . . . . 0.95999999999999996 108.151 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.705 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.4 p90 -146.54 -39.19 0.21 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.929 -1.108 . . . . 0.85999999999999999 112.665 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.61 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.096 -1.002 . . . . 0.66000000000000003 112.272 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.705 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -107.29 -1.42 21.72 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.409 -0.807 . . . . 0.48999999999999999 110.205 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.093 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.85 -41.86 0.77 Allowed Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 121.316 -0.865 . . . . 0.51000000000000001 112.09 179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.093 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.9 Cg_endo -67.34 -16.8 48.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 O-C-N 122.307 0.635 . . . . 0.56999999999999995 110.907 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -95.3 -25.99 16.1 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.935 -1.103 . . . . 0.68999999999999995 109.669 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -70.19 -33.99 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.775 -1.194 . . . . 0.41999999999999998 107.775 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.747 HD12 ' HG ' ' A' ' 14' ' ' LEU . 3.3 pt -90.7 18.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 118.978 -1.089 . . . . 0.31 108.385 176.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 27.4 p -55.23 -32.89 62.64 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.017 -1.052 . . . . 0.37 108.765 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.675 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.7 t -86.89 -55.05 0.37 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.57999999999999996 109.567 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.2 Cg_endo -84.49 44.22 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.159 1.24 . . . . 0.34000000000000002 112.03 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -175.77 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.014 -1.054 . . . . 0.44 110.556 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -58.49 -47.97 82.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.62 111.43 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.09 -19.47 4.99 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.234 -0.986 . . . . 0.40999999999999998 109.818 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.8 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.35 -40.94 29.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.13 -1.804 . . . . 0.42999999999999999 106.13 177.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -67.88 -35.54 78.69 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.283 -1.747 . . . . 1.0 106.283 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 85.3 mt -69.35 -43.56 73.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.745 -1.205 . . . . 0.48999999999999999 107.745 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -61.64 -33.85 74.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.967 -1.494 . . . . 0.40999999999999998 106.967 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.75 -44.79 80.51 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.782 0.801 . . . . 0.46999999999999997 109.076 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.52 -41.34 80.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.117 -0.697 . . . . 0.46000000000000002 109.117 178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.57 -20.23 55.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 107.341 -2.304 . . . . 0.28000000000000003 107.341 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 50.4 m -95.34 -24.67 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -1.158 . . . . 0.34000000000000002 109.23 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' SER . . . -91.24 -23.43 20.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 0.48999999999999999 110.084 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 -42.28 6.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.702 0.763 . . . . 0.72999999999999998 109.278 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -89.57 -34.01 16.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.715 -0.616 . . . . 0.35999999999999999 111.331 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.699 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -90.75 -41.21 11.39 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.681 -1.262 . . . . 0.44 110.843 -179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -83.92 -36.86 22.99 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.95 -1.094 . . . . 0.63 110.278 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -62.11 1.18 Allowed Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.589 -1.404 . . . . 0.68999999999999995 109.589 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.61 -13.68 74.73 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.446 -1.032 . . . . 0.62 110.833 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 64.37 30.75 13.14 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.436 -1.038 . . . . 0.85999999999999999 111.175 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.423 -0.798 . . . . 0.73999999999999999 110.237 179.612 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.893 0 N-CA-C 109.689 -1.365 . . . . 0.59999999999999998 109.689 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.797 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.12 -60.74 0.22 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.95 -1.13 . . . . 0.48999999999999999 107.95 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.783 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 39.3 p90 -146.47 -38.21 0.23 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 118.405 -1.318 . . . . 0.32000000000000001 113.237 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . . . -172.54 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.953 -1.092 . . . . 0.25 112.509 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 9' ' ' ILE . 3.7 pp -125.61 -1.42 7.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.35 -0.844 . . . . 0.29999999999999999 110.699 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.797 HG21 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -42.5 -33.89 0.73 Allowed Pre-proline 0 N--CA 1.496 1.85 0 C-N-CA 119.213 -0.995 . . . . 0.32000000000000001 111.969 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.0 Cg_endo -94.27 6.43 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 O-C-N 122.58 0.779 . . . . 0.23999999999999999 111.403 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 8.9 mtpt -110.27 -39.63 4.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.667 -1.27 . . . . 0.31 110.51 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 5' ' ' LEU . 2.2 pp -60.22 -28.96 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.015 -1.053 . . . . 0.32000000000000001 109.385 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.877 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.1 pp -92.31 17.69 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 118.062 -1.455 . . . . 0.22 109.452 177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 12.0 t -50.63 -41.3 54.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.864 -1.148 . . . . 0.28999999999999998 108.843 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.603 ' CB ' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -65.19 -59.99 8.76 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.452 -0.78 . . . . 0.33000000000000002 109.559 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 54.8 Cg_endo -83.39 32.66 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.995 1.13 . . . . 0.20999999999999999 112.314 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.719 ' CB ' HD13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -162.13 -57.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.57 -1.331 . . . . 0.32000000000000001 110.991 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.611 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -62.2 -47.23 85.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.358 -0.839 . . . . 0.64000000000000001 110.997 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.44 -20.83 1.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.34 -0.85 . . . . 0.23999999999999999 110.288 179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.99 -44.69 14.97 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.395 -1.706 . . . . 0.27000000000000002 106.395 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.3 tm? -63.61 -30.62 71.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.745 -1.946 . . . . 0.32000000000000001 105.745 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 16' ' ' LYS . 90.4 mt -73.1 -46.36 51.74 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.888 -1.152 . . . . 0.29999999999999999 107.888 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -58.75 -34.14 71.06 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.761 -1.57 . . . . 0.29999999999999999 106.761 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.46 -46.66 72.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.874 0.845 . . . . 0.20999999999999999 109.436 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -69.0 -39.68 80.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.241 0.543 . . . . 0.28000000000000003 109.776 179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -59.13 -23.11 56.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.501 -2.24 . . . . 0.16 107.501 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 28' ' ' SER . 18.8 m -95.35 -24.46 16.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.52 -0.988 . . . . 0.19 109.926 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.66 -15.92 24.83 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 0.20999999999999999 110.395 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -107.78 -36.24 6.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.459 -0.776 . . . . 0.48999999999999999 108.932 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -97.19 -30.18 13.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.23000000000000001 111.053 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -106.98 24.48 12.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.134 . . . . 0.28000000000000003 112.333 -178.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.4 p -114.51 -47.98 2.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.038 -1.039 . . . . 0.32000000000000001 110.205 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.35 55.26 4.22 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.62 -1.392 . . . . 0.39000000000000001 109.62 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . 138.26 -27.8 2.73 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.203 -1.559 . . . . 0.35999999999999999 109.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 75.6 138.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.653 0.739 . . . . 0.40000000000000002 111.307 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.949 -1.024 . . . . 0.51000000000000001 109.964 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.868 0 N-CA-C 109.728 -1.349 . . . . 0.81000000000000005 109.728 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.939 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.35 -60.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.33 -1.1 . . . . 0.91000000000000003 108.249 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.675 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 36.0 p90 -146.81 -39.2 0.21 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.633 -1.227 . . . . 0.75 113.192 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.55 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.58999999999999997 112.155 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.675 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -117.31 -4.28 11.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.104 -0.998 . . . . 0.46999999999999997 110.721 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.042 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.58 -41.87 2.08 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 118.992 -1.083 . . . . 0.39000000000000001 111.74 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.042 ' HD3' HG23 ' A' ' 6' ' ' ILE . 46.1 Cg_endo -69.69 -15.22 37.24 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 122.481 0.727 . . . . 0.46000000000000002 111.264 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 mppt? -99.33 -32.0 11.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.76 -1.212 . . . . 0.41999999999999998 109.623 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.607 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -61.84 -31.58 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.117 -1.068 . . . . 0.44 108.117 178.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HG ' ' A' ' 14' ' ' LEU . 7.0 pt -84.21 18.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 118.666 -1.214 . . . . 0.38 109.143 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.691 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 28.7 t -51.54 -40.73 60.23 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.77 -1.206 . . . . 0.37 108.831 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -70.13 -57.96 5.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.40000000000000002 109.507 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.7 Cg_endo -84.28 39.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.101 1.201 . . . . 0.32000000000000001 112.071 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -171.25 -59.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.78 -1.2 . . . . 0.47999999999999998 110.885 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.691 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -59.33 -47.26 86.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.292 -0.88 . . . . 0.75 111.054 -179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -53.16 -19.88 3.38 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.382 -0.927 . . . . 0.34000000000000002 109.834 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.805 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -80.5 -40.88 25.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.164 -1.791 . . . . 0.37 106.164 177.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.04 -33.23 73.27 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.42 -1.696 . . . . 0.56999999999999995 106.42 175.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 96.5 mt -70.89 -42.15 70.39 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.315 -1.365 . . . . 0.46000000000000002 107.315 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -62.42 -35.95 80.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.091 -1.448 . . . . 0.29999999999999999 107.091 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -63.16 -43.16 99.08 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.807 0.813 . . . . 0.41999999999999998 108.945 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.4 -39.23 76.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.71 -19.63 43.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 107.757 -2.137 . . . . 0.28000000000000003 107.757 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.4 OUTLIER -99.85 -23.81 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -1.156 . . . . 0.40999999999999998 109.308 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -87.65 -21.8 25.08 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.985 -1.072 . . . . 0.44 109.282 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.61 -44.43 5.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.113 -0.699 . . . . 0.51000000000000001 109.113 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -87.12 -43.24 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.73 -0.606 . . . . 0.33000000000000002 111.146 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -75.46 -10.47 59.48 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.797 -1.189 . . . . 0.46999999999999997 110.767 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 20.4 t -121.75 18.95 11.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.51000000000000001 110.52 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.76 57.05 0.03 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.148 -1.181 . . . . 0.40000000000000002 110.148 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.78 68.9 0.2 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.418 -1.473 . . . . 0.42999999999999999 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -93.44 -21.54 19.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.564 -0.962 . . . . 0.59999999999999998 110.728 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.502 -0.761 . . . . 0.94999999999999996 110.852 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.789 0 N-CA-C 109.704 -1.359 . . . . 0.66000000000000003 109.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.827 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.26 -60.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.155 -1.054 . . . . 0.64000000000000001 108.155 179.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.4 p90 -146.95 -39.35 0.2 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.764 -1.175 . . . . 0.35999999999999999 112.81 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.48 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.967 -1.083 . . . . 0.29999999999999999 112.228 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.8 pp -105.84 -1.34 24.37 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.491 -0.756 . . . . 0.35999999999999999 109.988 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.085 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -36.45 -41.95 0.71 Allowed Pre-proline 0 N--CA 1.503 2.179 0 C-N-CA 119.683 -0.807 . . . . 0.34000000000000002 112.183 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.085 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.2 Cg_endo -66.89 -17.01 51.41 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 122.276 0.619 . . . . 0.34000000000000002 110.837 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -99.06 -24.43 14.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.857 -1.152 . . . . 0.59999999999999998 109.457 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -29.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.314 -0.995 . . . . 0.33000000000000002 108.314 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.608 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -84.94 18.13 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.228 0 C-N-CA 118.659 -1.216 . . . . 0.28999999999999998 108.685 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.708 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.6 t -50.57 -40.53 52.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.721 -1.237 . . . . 0.28000000000000003 108.881 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -69.01 -58.44 6.38 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.29999999999999999 109.883 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.09 26.4 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.086 1.191 . . . . 0.25 112.39 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -157.83 -59.47 0.08 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.531 -1.355 . . . . 0.35999999999999999 111.014 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.708 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -62.05 -46.18 90.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.357 -0.839 . . . . 0.56999999999999995 111.104 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.862 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -21.21 1.17 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.358 -0.839 . . . . 0.20000000000000001 110.262 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.862 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 m -83.1 -45.21 14.26 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.472 -1.677 . . . . 0.20999999999999999 106.472 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -63.9 -29.65 70.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.895 -1.891 . . . . 0.32000000000000001 105.895 175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -73.3 -46.26 50.71 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 177.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -58.75 -36.12 73.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.595 -1.631 . . . . 0.48999999999999999 106.595 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.75 -47.27 75.8 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.821 0.82 . . . . 0.20000000000000001 109.23 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.21 -39.77 85.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.264 -0.643 . . . . 0.20000000000000001 109.264 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.22 -22.77 44.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.606 -2.198 . . . . 0.14999999999999999 107.606 177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.702 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 30.9 t -98.91 -25.71 14.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.245 -1.15 . . . . 0.38 109.712 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -86.65 -21.72 26.56 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.023 -1.048 . . . . 0.19 109.792 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.46 -42.51 5.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.209 -0.663 . . . . 0.29999999999999999 109.209 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -88.62 -42.82 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.20000000000000001 110.872 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.702 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -76.36 -13.8 60.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.719 -1.238 . . . . 0.28999999999999998 110.819 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 22.3 t -117.98 19.78 13.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.092 -1.005 . . . . 0.28000000000000003 110.489 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.42 53.53 0.02 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 110.487 -1.045 . . . . 0.28999999999999998 110.487 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.96 63.73 0.05 OUTLIER Glycine 0 N--CA 1.5 2.924 0 N-CA-C 109.965 -1.254 . . . . 0.23000000000000001 109.965 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.613 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 1.7 mm100 -76.06 -49.29 17.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.43 -1.041 . . . . 0.35999999999999999 110.287 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.838 -1.077 . . . . 0.53000000000000003 110.452 179.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.908 0 N-CA-C 109.636 -1.386 . . . . 0.53000000000000003 109.636 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.925 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -157.94 -59.85 0.08 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.343 -1.092 . . . . 0.57999999999999996 108.283 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.733 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 35.1 p90 -147.8 -38.96 0.19 Allowed 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 118.538 -1.265 . . . . 0.47999999999999998 113.233 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.45 -48.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.872 -1.143 . . . . 0.41999999999999998 112.187 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.7 pp -116.66 -3.37 11.77 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 110.762 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.038 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -40.32 -41.68 2.61 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 118.939 -1.105 . . . . 0.34999999999999998 111.552 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.038 ' HD3' HG23 ' A' ' 6' ' ' ILE . 46.6 Cg_endo -69.56 -15.21 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 122.521 0.748 . . . . 0.34000000000000002 111.308 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 mppt? -100.96 -30.75 11.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.769 -1.207 . . . . 0.46000000000000002 109.34 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.651 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -60.78 -29.93 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.379 -0.971 . . . . 0.31 108.379 178.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.62 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 9.3 pt -83.84 18.25 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 C-N-CA 118.595 -1.242 . . . . 0.27000000000000002 108.973 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 5.0 t -50.8 -41.77 57.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.637 -1.289 . . . . 0.42999999999999999 108.94 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.5 t -68.26 -58.2 7.84 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.407 -0.808 . . . . 0.38 109.963 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.69 26.16 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 O-C-N 123.264 1.139 . . . . 0.31 112.423 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -158.81 -61.1 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.602 -1.311 . . . . 0.42999999999999999 111.151 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.735 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 1.8 m-85 -60.23 -47.37 86.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 110.982 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.868 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.06 -20.26 0.93 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.366 -0.834 . . . . 0.28000000000000003 110.497 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.868 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.2 m -84.79 -44.31 13.42 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.547 -1.649 . . . . 0.29999999999999999 106.547 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -64.69 -29.16 70.15 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.045 -1.835 . . . . 0.81000000000000005 106.045 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 90.5 mt -75.83 -44.3 41.66 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.635 -1.246 . . . . 0.39000000000000001 107.635 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 m -60.35 -33.01 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.756 -1.572 . . . . 0.32000000000000001 106.756 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -64.96 -46.56 81.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.77 -0.826 . . . . 0.39000000000000001 108.77 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -68.99 -40.08 80.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.714 -0.847 . . . . 0.40000000000000002 108.714 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.74 -19.6 43.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.692 -2.163 . . . . 0.26000000000000001 107.692 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 5.1 p -97.56 -23.14 16.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.201 -1.176 . . . . 0.31 109.419 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.37 -19.79 22.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.048 -1.032 . . . . 0.39000000000000001 109.653 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.56 -33.15 8.19 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.487 0.66 . . . . 0.62 109.741 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -101.89 -29.07 12.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.38 111.728 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -92.54 -46.71 7.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 0.34000000000000002 111.146 -179.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.6 p -50.01 -28.95 7.7 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.381 -0.825 . . . . 0.46000000000000002 112.036 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.8 6.15 75.54 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 121.092 -1.005 . . . . 0.71999999999999997 111.422 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 119.58 -16.99 10.37 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.913 -1.346 . . . . 0.56999999999999995 110.46 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 63.2 tp60 67.16 -75.95 0.06 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.753 -0.851 . . . . 0.62 110.895 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.968 -1.015 . . . . 1.2 110.57 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.687 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 109.589 -1.404 . . . . 1.01 109.589 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -156.77 -60.64 0.09 Allowed 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.36 -1.082 . . . . 0.93999999999999995 108.088 179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.1 p90 -146.53 -39.49 0.21 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 118.906 -1.118 . . . . 0.68000000000000005 112.741 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.69 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.211 -0.996 . . . . 0.5 112.307 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.685 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 1.9 pp -106.92 -1.55 22.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.495 -0.753 . . . . 0.46999999999999997 110.074 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.133 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -37.13 -41.72 0.82 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.321 -0.862 . . . . 0.47999999999999998 112.133 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.133 ' HD3' HG23 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -66.79 -16.06 49.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.844 0.623 . . . . 0.48999999999999999 110.871 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -98.54 -25.5 14.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.853 -1.154 . . . . 0.72999999999999998 109.629 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -64.8 -30.05 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.63 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 7.6 pt -86.36 19.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 118.578 -1.249 . . . . 0.39000000000000001 108.494 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 9.2 t -50.76 -41.22 56.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.922 -1.111 . . . . 0.33000000000000002 108.97 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.3 t -65.28 -59.18 10.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.388 -0.82 . . . . 0.34999999999999998 109.545 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 10' ' ' ILE . 55.5 Cg_endo -82.14 29.19 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.311 1.164 . . . . 0.31 112.205 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -159.17 -58.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.535 -1.353 . . . . 0.38 111.07 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.616 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -63.04 -47.64 82.15 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.425 -0.797 . . . . 0.94999999999999996 111.112 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.86 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.71 -21.5 1.08 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.296 -0.877 . . . . 0.29999999999999999 110.251 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.86 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.23 -44.74 14.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.495 -1.669 . . . . 0.34000000000000002 106.495 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -64.33 -30.11 71.17 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.035 -1.839 . . . . 0.40000000000000002 106.035 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' LYS . 85.6 mt -74.06 -45.32 50.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.774 -1.195 . . . . 0.45000000000000001 107.774 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -59.01 -36.2 74.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.463 -1.68 . . . . 0.64000000000000001 106.463 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.11 -47.48 77.02 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.686 0.755 . . . . 0.33000000000000002 109.406 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -66.11 -39.51 84.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.432 -0.581 . . . . 0.31 109.432 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.28 -23.4 47.66 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 107.534 -2.226 . . . . 0.27000000000000002 107.534 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.721 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 45.0 t -97.19 -25.12 15.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.214 -1.168 . . . . 0.51000000000000001 109.888 178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -88.12 -22.6 24.02 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.988 -1.07 . . . . 0.34999999999999998 110.012 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.05 -43.38 5.51 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.644 0.735 . . . . 0.67000000000000004 109.29 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -87.66 -35.52 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.72 -0.613 . . . . 0.37 111.023 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -91.8 -58.52 2.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.775 -1.203 . . . . 0.34999999999999998 110.428 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.7 t -71.06 -17.27 62.61 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.887 -1.133 . . . . 0.53000000000000003 110.857 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.19 -64.3 0.57 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.512 -1.435 . . . . 0.54000000000000004 109.512 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.03 -5.96 87.22 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.475 -1.014 . . . . 0.51000000000000001 111.092 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.46 31.35 17.15 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.222 -1.164 . . . . 0.78000000000000003 111.127 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.823 -1.084 . . . . 0.65000000000000002 110.199 179.631 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.878 0 N-CA-C 109.73 -1.348 . . . . 0.82999999999999996 109.73 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.919 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -160.54 -59.68 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.081 -1.081 . . . . 0.78000000000000003 108.081 179.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.666 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 34.6 p90 -146.29 -39.35 0.22 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.101 -1.04 . . . . 0.70999999999999996 112.527 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.44 -54.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.54000000000000004 112.296 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.673 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 2.0 pp -110.62 -0.78 17.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.491 -0.755 . . . . 0.35999999999999999 110.412 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.009 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -38.54 -40.67 1.04 Allowed Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 119.46 -0.896 . . . . 0.40000000000000002 112.065 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.009 ' HD3' HG23 ' A' ' 6' ' ' ILE . 44.9 Cg_endo -68.92 -14.66 39.15 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 CA-C-N 118.909 0.646 . . . . 0.45000000000000001 110.728 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -100.37 -26.47 13.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.902 -1.124 . . . . 0.56999999999999995 109.751 179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -67.06 -30.91 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.758 -1.201 . . . . 0.26000000000000001 107.758 178.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.756 HD12 ' HG ' ' A' ' 14' ' ' LEU . 2.6 pt -88.74 19.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 118.696 -1.201 . . . . 0.27000000000000002 108.611 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.1 p -54.5 -32.11 57.3 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.762 -1.211 . . . . 0.33000000000000002 108.9 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.544 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.2 t -85.77 -54.74 0.41 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.435 -0.791 . . . . 0.35999999999999999 110.446 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.685 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 53.1 Cg_endo -80.61 13.94 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.027 1.151 . . . . 0.37 113.025 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -146.8 -60.04 0.29 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.553 -1.342 . . . . 0.38 110.808 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -57.44 -44.5 84.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.404 -0.81 . . . . 0.58999999999999997 110.719 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.855 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -51.1 -21.83 2.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.495 -0.753 . . . . 0.34000000000000002 110.393 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.855 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.7 m -82.73 -44.44 15.62 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 106.519 -1.66 . . . . 0.34999999999999998 106.519 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -63.68 -29.58 70.79 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.809 -1.923 . . . . 0.38 105.809 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -74.14 -46.0 45.21 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.092 -1.077 . . . . 0.44 108.092 178.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.53 -34.69 71.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.547 -1.649 . . . . 0.40000000000000002 106.547 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -67.47 -47.54 69.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.75 0.786 . . . . 0.31 109.389 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -67.08 -40.81 86.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.344 0.592 . . . . 0.34000000000000002 109.423 178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -58.54 -22.36 52.0 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.574 -2.21 . . . . 0.19 107.574 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.648 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 22.3 m -97.48 -24.84 15.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.509 -0.995 . . . . 0.23000000000000001 109.556 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -87.04 -21.0 26.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.012 -1.055 . . . . 0.34000000000000002 109.738 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 -45.95 5.11 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.756 0.789 . . . . 0.82999999999999996 108.919 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.2 t -83.81 -45.0 13.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.78 -0.575 . . . . 0.29999999999999999 110.749 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.648 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -81.93 -50.98 8.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.834 . . . . 0.29999999999999999 110.72 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -87.58 25.34 1.48 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.984 -1.072 . . . . 0.51000000000000001 110.624 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.06 -60.13 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.72 -1.352 . . . . 0.5 109.72 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 32' ' ' GLN . . . -90.21 32.01 5.13 Favored Glycine 0 N--CA 1.5 2.963 0 O-C-N 121.412 -1.052 . . . . 0.5 111.041 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 4.4 tt0 69.07 -58.75 0.49 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.523 -0.987 . . . . 0.95999999999999996 112.583 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 117.636 -1.173 . . . . 0.72999999999999998 111.386 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 N-CA-C 109.706 -1.358 . . . . 0.98999999999999999 109.706 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.781 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -149.99 -60.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.033 -1.099 . . . . 0.89000000000000001 108.033 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.732 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 38.3 p90 -145.52 -37.42 0.27 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 118.612 -1.235 . . . . 0.70999999999999996 113.011 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . -175.05 -44.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.986 -1.071 . . . . 0.56000000000000005 112.428 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.732 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -123.95 -0.47 8.44 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.262 -0.899 . . . . 0.46000000000000002 110.747 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.782 ' CG2' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -42.69 -33.5 0.69 Allowed Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 118.961 -1.095 . . . . 0.65000000000000002 111.956 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' CG2' ' A' ' 6' ' ' ILE . 41.1 Cg_endo -91.41 0.01 4.64 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 O-C-N 122.558 0.768 . . . . 0.58999999999999997 111.672 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 5' ' ' LEU . 5.2 mppt? -106.65 -37.57 6.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.708 -1.245 . . . . 0.44 109.892 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -61.69 -33.34 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.41999999999999998 108.487 178.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 18.9 pt -84.29 20.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 118.621 -1.232 . . . . 0.40999999999999998 108.455 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.666 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 6.6 t -50.59 -41.79 55.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.843 -1.161 . . . . 0.44 108.998 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.655 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.9 t -65.36 -58.92 10.74 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.337 -0.852 . . . . 0.35999999999999999 109.641 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.3 Cg_endo -82.39 27.85 0.58 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.039 1.159 . . . . 0.26000000000000001 112.313 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -158.96 -59.03 0.07 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.593 -1.317 . . . . 0.46000000000000002 111.206 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.6 OUTLIER -61.95 -47.59 84.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.426 -0.796 . . . . 0.80000000000000004 110.924 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.853 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -50.02 -20.83 1.04 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.347 -0.846 . . . . 0.34000000000000002 110.363 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -83.96 -44.01 14.63 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.589 -1.634 . . . . 0.40000000000000002 106.589 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -66.53 -27.53 67.83 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.323 -1.732 . . . . 0.59999999999999998 106.323 175.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' LYS . 86.3 mt -76.09 -43.61 42.68 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.09 -1.448 . . . . 0.46999999999999997 107.09 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -60.41 -34.93 74.64 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -62.24 -45.99 90.86 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.764 0.792 . . . . 0.46000000000000002 108.951 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -69.81 -39.37 77.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.23 -0.656 . . . . 0.46999999999999997 109.23 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -57.02 -20.8 35.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.708 -2.157 . . . . 0.34000000000000002 107.708 177.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.577 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.2 p -96.05 -25.56 15.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.162 -1.199 . . . . 0.47999999999999998 109.565 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -90.17 -22.14 21.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.232 -0.918 . . . . 0.42999999999999999 110.08 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -103.18 -40.41 6.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.529 0.681 . . . . 0.48999999999999999 109.502 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -90.7 -35.47 14.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.40999999999999998 110.941 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -95.09 -49.95 5.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.101 -0.999 . . . . 0.46000000000000002 110.368 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.554 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . 18.8 m -85.58 -9.37 57.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.56000000000000005 110.973 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.4 -72.19 0.72 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.201 -1.56 . . . . 0.5 109.201 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -70.82 -59.51 5.11 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.871 -1.292 . . . . 0.5 109.871 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 66.79 -59.9 0.36 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.761 -0.847 . . . . 0.95999999999999996 111.058 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.57 -0.729 . . . . 1.1299999999999999 111.604 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.808 0 N-CA-C 109.729 -1.348 . . . . 0.45000000000000001 109.729 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.907 ' N ' HG21 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -158.98 -59.55 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.36 -1.083 . . . . 0.66000000000000003 108.092 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CE2' ' HG ' ' A' ' 5' ' ' LEU . 33.9 p90 -146.47 -38.5 0.22 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.09 -1.044 . . . . 0.46000000000000002 112.483 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.66 -53.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 0.39000000000000001 112.351 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.715 ' HG ' ' CE2' ' A' ' 3' ' ' PHE . 2.4 pp -110.75 -1.71 16.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.413 -0.805 . . . . 0.28999999999999998 110.457 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.052 HG23 ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -39.04 -40.48 1.14 Allowed Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.211 -0.931 . . . . 0.34999999999999998 112.16 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.052 ' HD3' HG23 ' A' ' 6' ' ' ILE . 47.1 Cg_endo -70.37 -12.41 31.68 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 CA-C-N 118.946 0.659 . . . . 0.35999999999999999 110.931 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.33 -32.91 11.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.873 -1.142 . . . . 0.34999999999999998 109.702 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -64.04 -30.4 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.31 108.495 178.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' C ' ' HD2' ' A' ' 13' ' ' PRO . 10.2 pt -85.14 17.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.524 -1.27 . . . . 0.35999999999999999 108.989 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 15' ' ' PHE . 29.6 t -50.97 -40.02 56.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.28999999999999998 108.968 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 1.4 t -70.02 -58.03 5.63 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.31 109.795 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 55.6 Cg_endo -83.09 30.19 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.047 1.164 . . . . 0.32000000000000001 112.373 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -160.08 -58.73 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.695 -1.253 . . . . 0.53000000000000003 110.655 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HB2' ' HA ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -63.95 -46.79 83.11 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 111.202 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.866 ' HD3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -49.98 -21.73 1.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.233 -0.917 . . . . 0.28999999999999998 110.256 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.866 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 1.3 m -82.59 -45.06 15.07 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.668 -1.605 . . . . 0.27000000000000002 106.668 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.81 -28.54 69.63 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.22 -1.77 . . . . 0.46000000000000002 106.22 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . 2.2 mt -74.57 -42.91 57.91 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 107.33 -1.359 . . . . 1.1399999999999999 107.33 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -60.13 -34.16 73.14 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.088 -1.449 . . . . 0.28000000000000003 107.088 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -66.48 -44.84 81.56 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.899 0.857 . . . . 0.28999999999999998 109.124 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -70.01 -40.76 78.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.026 -0.731 . . . . 0.33000000000000002 109.026 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 27' ' ' SER . . . -60.5 -19.18 53.22 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 107.77 -2.132 . . . . 0.23000000000000001 107.77 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 47.6 m -98.83 -22.51 15.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.26000000000000001 109.48 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.62 -21.66 20.69 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.145 -0.972 . . . . 0.28999999999999998 109.484 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -36.45 7.92 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.422 0.63 . . . . 0.69999999999999996 109.67 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -98.1 -19.96 17.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.728 . . . . 0.26000000000000001 111.652 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -111.32 -61.11 1.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.92 -1.113 . . . . 0.25 111.072 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -94.35 24.12 4.69 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.086 -1.009 . . . . 0.40999999999999998 111.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.65 37.0 0.78 Allowed Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.987 -1.245 . . . . 0.31 109.987 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.69 68.85 0.15 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.749 -1.74 . . . . 0.33000000000000002 108.749 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 33' ' ' GLU . 1.2 pm0 -94.05 -171.0 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.676 -0.896 . . . . 0.46000000000000002 111.03 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 pm0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.621 -1.18 . . . . 0.56999999999999995 111.061 179.995 . . . . . . . . 1 1 . 1 stop_ save_